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COMMENTS
FEDERAL GENETIC NONDISCRIMINATION
LEGISLATION: THE NEW "RIGHT" AND THE
RACE TO PROTECT DNA AT THE LOCAL, STATE,
AND FEDERAL LEVEL
Katherine A. Hathaway'
When the Human Genome Project (HGP) officially began in 1990,' it
was overshadowed by the Americans with Disabilities Act (ADA),2 the
new federal legislation aimed at combating discrimination based on a
person's disability. While the ADA was the result of a massive
legislative effort to extend protection to people with physical or mental
impairments,3 few were discussing the legal implications of the Human
+ J.D. Candidate, May 2003, The Catholic University of America, Columbus School of
Law. The author would like to thank Professor Roger Hartley for his advice and support
and her family for providing indispensable diversions and perspective during the writing
process.
1. See Daniel Drell, The Human Genome Project: What a Legal Assistant Needs to
Know, 27 J. LEGAL ASSISTANTS 2 available at http://www.ornl.gov/hgmis/publicat/
miscpubs/legalasst.html (Aug. 2, 2000); see also National Human Genome Research
Institute, The Human Genome Project, at http://www.genome.gov/page.cfm?pagelD=
10001694 (last visited Aug. 18, 2002). The Human Genome Project began in 1986 with
funding from the U.S. Department of Energy. See Drell, supra. In 1990, a joint effort was
launched by the Department of Energy and the National Institutes of Health. See id.
2. Americans with Disabilities Act of 1990, 42 U.S.C. §§ 12101-12213 (2000).
3. See 42 U.S.C. § 12101(a). Congress enacted the ADA because it found that
discrimination against disabled individuals was taking place in "such critical areas as
employment, housing, public accommodations, education, transportation, communication,
recreation, institutionalization, health services, voting, and access to public services." Id. §
12101(a)(3). Additionally, Congress found that disabled individuals persistently
encountered discrimination in many forms, including "outright intentional exclusion, the
discriminatory effects of architectural, transportation, and communication barriers;" the
failure to make modifications to building structures; exclusionary practices; "relegation to
lesser services, programs, activities, benefits[, and] jobs." Id. § 12101(a)(5). Congress also
found that "individuals with disabilities are a discrete ... minority who have been faced
with restrictions and limitations" and "relegated to a position of political powerlessness in.
. . society, based on characteristics beyond their control, which results in stereotypic
assumptions not indicative of the individual." Id. § 12101(a)(7). Congress needed to enact
legislation because unfair discrimination denies disabled persons "the opportunity to
compete on an equal basis and to pursue opportunities for which our free society is
justifiably famous." See id. § 12101(a)(9). The purpose of the ADA is:
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Genome Project.4  More than a decade later, with the HGP having
accomplished its first major goal, disability discrimination is no longer
the only evil.5 Possibly more pervasive and wide-reaching than disability
discrimination, genetic discrimination has quickly surfaced as the
unwanted by-product of a heralded scientific milestone Today,
discrimination based on one's genetic make-up presents individuals with
more serious privacy concerns, more pressing and immediate legal issues,
to provide a clear and comprehensive national mandate for the elimination of
discrimination against individuals with disabilities;
to provide clear, strong, consistent, enforceable standards addressing
discrimination against individuals with disabilities;
to ensure that the Federal Government plays a central role in enforcing the
standards established in this chapter on behalf of individuals with disabilities.
Id. § 12101(b).
4. See National Human Genome Research Institute, About ELSI, at
http://www.nhgri.nih.gov/ELSI/aboutels.html (last visited Aug. 18, 2002) (noting that in
1989, the National Institutes of Health-Department of Energy Joint Working Group on
Ethical, Legal, and Social Implications of Human Genome Research was only beginning
to anticipate the potential ramifications of the HGP); see also Ari Patrinos and Daniel W.
Drell, Introducing the Human Genome Project: Its Relevance, Triumphs, and Challenges,
36 JUDGES' J. 3 (1997) (tracking the development of the HGP and noting the early
recognition of the legal issues related to mapping the human genome, while stating that
many of the issues ELSI deals with are not new to medicine), available at http://www.
ornl.gov/FechResources/Human-Genome/publicat/judges/drell.htm (last visited Aug. 18,
2002). The National Institutes of Health's National Human Genome Research Institute
established, and the Department of Energy funded, the Ethical, Legal and Social
Implications of the Human Genome Project (ELSI) in 1989 to "anticipate and address the
implications for individuals and society of mapping and sequencing the human genome."
See National Human Genome Research Institute, About ELSI, supra.
5. See Rick Weiss & Justin Gillis, Teams Finish Mapping Human DNA: Clinton,
Scientists Celebrate 'Working Draft' of Human Genetic Blueprint, WASH. POST, June 27,
2000, at Al (reporting the dual achievement reached by the HGP and Celera Genomics in
identifying and placing in order between ninety-seven and ninety-nine percent of the
molecular "letters" of the DNA in virtually every type of human cell). On June 26, 2000,
President Clinton announced that the human genome had been mapped by two research
groups, the federally funded Human Genome Project, and a private company, Celera
Genomics, Inc. See id. The goal of the HGP was "to uncover the entire genetic
architecture of human chromosomes." Richard S. Fedder, To Know or Not to Know:
Legal Perspectives on Genetic Privacy and Disclosure of an Individual's Genetic Profile, 21
J. LEGAL MED. 557 (2000) (footnote omitted). The "working draft" that was announced
in June 2000 revealed the location and order of 3.12 billion base pairs of the human
genome. Id. at 557-58.
6. See Americans with Disabilities Act of 1990, 42 U.S.C. § 12101(a)(1) (2000)
(finding that at the time of the ADA's enactment, 43 million Americans had disabilities).
7. See Fulfilling the Promise of Genetics Research: Ensuring Nondiscrimination in
Health Insurance and Employment: Hearings on S.318 Before the Senate Comm on
Health, Educ., Labor and Pensions, 107th Cong. (July 25, 2001) (statement of Kathleen
Zeitz, National Breast Cancer Coalition) [hereinafter 107th Congress HELP Hearing],
available at National Breast Cancer Coalition Web Page, http://www.natlbcc.org/bin/
index.asp?strid=475&depid=3 (last visited Aug. 29, 2002).
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and a growing sense of caution with regard to daily activities than any
other time in recent memory.' The "old" evil of disability discrimination
is being revisited and put on center stage, albeit in a different form.9
Despite a host of immense legal implications, the sequencing of the
human gene has proven to be one of the most important scientific
breakthroughs in modern times.0 The significance for the medical
community has been astounding, as researchers have been successful in
determining the genetic cause and hereditary factors of, for example,
heart disease, diabetes, Parkinson's disease, bipolar illness, and asthma."
According to Dr. Francis S. Collins, Director of the National Human
Genome Research Institute (NHGRI):
We are daily gaining insights into the mysteries of the human
cell, how it works, and why sometimes... it doesn't.... These
revelations hold within them the promise of a true
transformation of medical practice. Quite possibly before the
end of the first decade of this new millennium, each of us may
be able to learn our individual susceptibilities to common
disorders, in some cases allowing the design of a program of
effective individualized preventive medicine focused on lifestyle
changes, diet and medical surveillance to keep us healthy. 2
The advantage of knowing the sequence of human genes is that it
enables researchers and scientists to study the structure and organization
of our DNA in chromosomes and establish the blueprint of our
individual biological make-up. 3 To understand an individual's genes is
8. See T. Shawn Taylor, Job Gene Tests Raise Alarm, Many Predict Discrimination
by Employers, Cm. TRIB., Sept. 3,2001, at 1 (noting the growing concern generated by the
newly mapped human genome and reporting the plight of a railroad employee whose
blood was tested without his knowledge).
9. See id. Taylor's article recounts the story of Terri Seargent, a 45-year-old woman
who discovered that she carried a gene that made her susceptible to a lung disease. See id.
She began a $4,000 per month treatment to protect her lungs from any further damage.
Id. Seargent subsequently was fired from her job, despite a good performance review, and
believed her employer fired her because her genetic disorder was affecting its bottom line.
Id.
10. See Weiss & Gillis, supra note 5 (relating President Clinton's remarks that
"[w]ithout a doubt, this is the most important, most wondrous map ever produced by
humankind").
11. Hearings on Genetic Information in the Workplace: Hearing Before the Senate
Comm. on Health, Educ., Labor and Pensions, 106th Cong. (July 20, 2000) [hereinafter
106th Congress, HELP Hearing] (testimony of Francis S. Collins, M.D., Ph.D., Director of
National Human Genome Research Institute), available at http://www.nhgri.nih.gov/
Policy-and-publicaffairs/Legislation/francis_72000_test.htm (last visited Aug. 18, 2002).
12. Id.
13. See Paul Steven Miller, Is There a Pink Slip in My Genes? Genetic Discrimination
in the Workplace, 3 J. HEALTH CARE L. & POL'Y 225, 227-28 (2000) (stating that "[g]enes
2002]
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to have complete and unhindered access to the instructions that make
that person who he or she is.'
4
Genetic advances revolutionize biological research and medical
practice because they allow scientists to look beyond symptoms and
sicknesses and see what kinds of predispositions each of us has
embedded in our DNA. 5 This, in turn, will lead to more effective
therapies and preventive measures that will ensure that people with
genetic flaws (i.e. almost all of us) live longer, healthier lives. 6 The
genetic tests that flow from these advances provide information about
the likelihood of passing on genetic conditions to offspring and the
increased risk of future disease or disability; they can even predict early
death due to disease or disability. 7
represent the blueprint for each individual's biological make-up" and that by identifying
certain genes, "one can determine an individual's likelihood of manifesting certain traits,
including disease and other disorders, or of passing along those traits to offspring"); see
also Oak Ridge National Laboratory, Frequently Asked Questions, at http://www.ornl.
gov/hgmis/faq/faqsl.html (last visited Aug. 8, 2002) (The Human Genome Project "will
reap fantastic benefits for humankind, some that we can anticipate and others that will
surprise us. Generations of biologists and researchers will be provided with detailed DNA
information that will be key to understanding the structure, organization, and function of
DNA in chromosomes."); see also Oak Ridge National Laboratory, The Science Behind
the Human Genome Project: Basic Genetics, Genome Draft Sequence, and Post-Genome
Science, at http://www.ornl.gov/hgmis/project/info.html (last visited Aug. 29, 2002)
(explaining the complex science behind the human genome).
14. See Patrinos & Drell, supra note 4.
15. See Department of Labor, Department of Health and Human Services, Equal
Employment Opportunity Commission, and Department of Justice, Genetic Information
and the Workplace, Jan. 20, 1998 [hereinafter Interagency Report], at http://www.nhgri.
nih.gov/HGP/Reports/genetics-workplace.html (last visited Aug. 23, 2002) (reporting that
knowledge of genetics can help a person prevent or reduce the likelihood of illness and
can even help reduce an individual's health care costs); see also 106th Congress, HELP
Hearing, supra note 1. (testimony of Francis S. Collins) (stating that the HGP will enable
society to better understand and more effectively treat diseases).
16. See 106th Congress, HELP Hearing, supra note 11 (testimony of Francis S.
Collins). Collins testified:
These same discoveries about genetics likely will lead us to predict who will
respond most effectively to a particular drug therapy, and who may suffer a side
effect and ought to avoid that particular drug. Furthermore, these remarkable
advances are expected to lead us to the next generation of designer drugs,
focused in a much more precise way on the molecular basis of common illnesses,
giving us a much more powerful set of targeted interventions to treat disease.
Id.
17. See Ilene V. Goldberg, Genetic Information Privacy and Discrimination, 20
HEALTH CARE MANAGER 19 (2001), available at 2001 WL 17480550 (citing the range of
genetic tests that have become available in recent years).
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These obvious medical advantages bring with them a distinct and
severe set of legal repercussions.18 Issues of privacy, fair employment,
and health insurance have arisen recently, as have the use of genomics in
clinical trials, counseling, education and training, family relations, and
social classification." Presently, as researchers continue their study of
human genes and DNA, the majority of citizens are left to wonder how
these medical and scientific advances will affect them' 3 Testifying before
the Senate Committee on Health, Education, Labor and Pensions
(HELP), Dr. Francis S. Collins, Director of the HGP and NHGRI,
stated, "It is estimated that all of us carry dozens of glitches in our DNA
- so establishing principles of fair use of this information is important for
all of us."'" This conclusion - that misuse of a person's genetic
information is a problem - is not without statistical support. A Harvard
Medical School study published in 1996 documented over 200 cases of
genetic discrimination. 2 Increasingly, genetic privacy is becoming not
18. See Miller, supra note 13, at 226 (focusing on one of the results of the HGP,
employment discrimination, as an emerging issue important to all workers as genetic
testing becomes more common); see also 106th Congress, HELP Hearing, supra note 11
(testimony of Francis S. Collins) (testifying that despite the huge success that mapping the
human genome represented, genetic information can also be used as the basis for
discrimination in obtaining employment and health insurance).
19. See Drell, supra note 1. In 1990, the HGP ELSI group identified a list of issues it
included in its research agenda: science policy issues (including intellectual property);
clinical practice issues (including disclosure and counseling practices); health policy issues
(including public health and allocation of resources); privacy issues (including definition of
genetic privacy and databanking standards); civil rights issues (including employment,
health, life and disability insurance, social discrimination, and race); and educational
policy issues (including clinical education models and health professional training). Id.
20. See John A. MacDonald, Congress Takes Up Genetic Privacy, HARTFORD
COURANT, Aug. 17, 2001, at Al. (citing the concerns of Dr. Francis S. Collins that
potential misuse of genetic information could preclude many individuals from getting the
care they need and reporting that one-third of those asked to participate in a recent
genetic study refused because of the fear of misuse of their genetic information).
21. 106th Congress, HELP Hearing, supra note 11 (testimony of Francis S. Collins).
22. See Dangerous Legacies: New Gene Tests Provide Fresh Grounds for
Discrimination, U.S. NEWS & WORLD REPORT, Nov. 10, 1997, available at 1997 WL
8332942; see also Interagency Report, supra note 15. Two of the 200 cases of
discrimination chronicled in the study were those of Jamie Stephenson and Theresa
Morelli. See Tim Friend, Researchers Uncover Genetic Discrimination, USA TODAY, Apr.
12, 1996, available at http://www.usatoday.com/life/health/ins461.htm. Stephenson's family
health insurance coverage was canceled when the company found out that her son had a
genetic disorder that causes mental retardation. Morelli, who tried to obtain a disability
insurance policy in the event she was ever injured, was denied coverage because her
medical records revealed that her father had Huntington's disease. Id. Cases of
discrimination are not limited to insurance. One individual revealed to a potential
employer that he was a carrier of a single mutation for Gaucher's disease. See Interagency
Report, supra note 15. Even though he would not develop this disease himself, he had the
2002]
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just a goal, but a mandate, as individuals are demanding legal protection
and legislators are beginning to give the topic serious consideration. 
3
Currently, there is very little legal protection available both on the
federal and state level to combat genetic discrimination. 2 Various
federal laws, such as the ADA, 2' and state laws offer questionable and
inconsistent safeguards at best.26  Because there has not yet been a
leading case on genetic discrimination, we cannot know for sure whether
the laws presently on the books are adequate.27 Recent attempts to enact
federal legislation have been limited to protection in health insurance
and employment, but genetic-based discrimination reaches even further
than those two areas2 Most state laws have also been limited to health
insurance and employment, and only one is comprehensive enough to
ability to pass it on to his children. Id. Having no bearing on his own job ability, his
genetic status caused him to be subsequently denied a job. Id. Similarly, a 53-year-old
man "revealed that he had hemochromatosis but was asymptomatic." Id. He was first
told by the employer that it was unable to provide him with health insurance because of
his genetic condition. Id. The employer later informed him that it would not be able to
hire him because of his genetic condition. Id.
23. See MacDonald, supra note 20 (noting that after five years of stalled action,
Congress "is beginning to move legislation that would write the prohibition into federal
law"). See generally Genetic Nondiscrimination in Health Insurance and Employment
Act, S.318, 107th Cong. (2001); Genetic Nondiscrimination Insurance and Employment
Act, H.R. 602, 107th Cong. (2001) available at http://thomas.loc.gov.
24. See Congressional Research Service, Genetic Information: Legal Issues Relating to
Discrimination and Privacy, Report for Congress, RL30006, 4, at http://www.cnie.org/nle/
crsreports/science/st-55.pdf.
25. 42 U.S.C. § 12101 (2000).
26. See Congressional Research Service, supra note 24, at 15 (noting that current
state statutes vary in approach and substantive provisions and that most state statutes are
limited by state insurance laws due to an ERISA preemption provision).
27. See id. at 10 (stating that so far there have been no reported cases addressing the
issue of whether the ADA covers genetic discrimination).
2& See id. at 16 (noting that a number of bills have been introduced in Congress on
genetic issues but that they do not receive congressional action); see also Patrinos & Drell,
supra note 4 (stating that "the list of... issues is long and virtually all of them have legal
ramifications). This list includes:
[t]he fair use of genetic information; the impact on genetic counseling and
medical practice; the effects on personal reproductive decisions; past uses and
misuses of genetic information; privacy implications of personal genetic
information in various settings, e.g., the work place, schools, or in the context of
adoptions; issues of the commercialization and intellectual property protection of
genome results, including DNA sequences; conceptual and philosophical
implications; implications of personal genetic variation; and genetic literacy and
the understanding of genetic information, particularly information related to
complex conditions that involve multiple genes and genetic-environmental
interactions.
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provide for all types, of genetic discrimination. 29 It is therefore imperative
for Congress to take the initiative by enacting far-reaching legislation
that will provide ample protection for any and all kinds of genetic
discrimination.0
This Comment examines the current debate concerning the use of an
individual's genetic information and the scope of the legal protection
currently available, as well as proposed legislation to safeguard against
an invasion of this private information. Part I will survey the current
legal protections available under federal and state law as they concern
the legal and ethical repercussions of the Human Genome Project. Part I
will also introduce the proposed federal legislation on genetic
nondiscrimination. Part II will study and compare the proposed federal
legislation and the enacted laws at the state and municipal levels,
concluding that despite laws at the local, state, and federal. level,
significant gaps in coverage and severe loopholes linger. In Part III, this
Comment proposes that a thorough overhaul of our country's civil rights
laws, including the ADA, should be considered to ensure all genetic
information is truly private and protected.
I. FEDERAL NONDISCRIMINATION LEGISLATION: FROM ENSURING
THAT NO AMERICAN WOULD BE DISCRIMINATED AGAINST ON THE
BASIS OF DISABILITY TO A LIMITED FORUM FOR PREDISPOSITIVE
PROTECT1ION
A. The Americans with Disabilities Act and the Supreme Court's
Narrowing Interpretations of "Person with a Disability"
There is little disagreement that "[t]here are no federal laws that
directly and comprehensively protect against abuses in the gathering or
use of genetic information . ,3" Still, it has been argued that the
Americans with Disabilities Act (ADA)32 and its counterpart, the
29. See Genetic Privacy Act, N.J. STAT. ANN. §§ 10:5-43 - 10:5-49 (West Supp. 2002);
see also Natalie Ann Stepanuk, Comment, Genetic Information and Third Party Access to
Information: New Jersey's Pioneering Legislation as a Model for Federal Privacy
Protection of Genetic Information, 47 CATH. U. L. REV. 1105, 1122-32 (1998) (analyzing
the New Jersey legislation, which takes a privacy approach instead of an anti-
discrimination approach).
30. See MacDonald, supra note 20 (citing Karen H. Rothenberg, a University of
Maryland law professor who specializes in genetics issues, who stated that neither current
state laws nor the limited federal laws provide enough protection against genetic
discrimination).
31. Interagency Report, supra note 15.
32. 42 U.S.C. § 12101 et seq. (2000).
2002]
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Rehabilitation Act of 1973,3" would apply to genetic discrimination in
employment and possibly health insurance. 4
The ADA prohibits discrimination against an individual with a
disability in employment, public services, public accommodations, and
communications. To bring suit under the ADA, a plaintiff must be a
"qualified individual with a disability" who "with or without reasonable
accommodation, can perform the essential functions of the employment
position that such individual holds or desires., 36  An individual with a
disability is further defined as someone who has "a physical or mental
impairment that substantially limits one or more of the major life
activities," has "a record of such an impairment," or is "regarded as
having such an impairment."" Thus, to receive protection and to recover
under the ADA, a plaintiff must prove he or she falls into one of the
three definitions of disabled.38
While the ADA does not specifically address genetic information, it
does protect individuals with symptomatic genetic disabilities in the same
way as individuals with other disabilities. 39  However, it does not
expressly protect against discrimination based on "unexpressed genetic
33. 29 U.S.C. § 791 et seq. (2000).
34. See 106th Congress, HELP Hearing, supra note 11 (testimony of Paul Steven
Miller, Commissioner of the Equal Employment Opportunity Commission), available at
http://www.nhgri.nih.gov/Policy-and-public-affairs/Legislation/miller-testimony.htm (last
visited Apr. 20, 2002) (concluding that the ADA "can be interpreted to prohibit
employment discrimination based on genetic information"). With regard to whether
genetic discrimination in health insurance would be covered under the ADA, one scholar
has noted:
Even if the ADA does apply to asymptomatic individuals with genetic defects...
in the workplace . . . it most likely will not apply to cases of insurance
discrimination. Title IV, section 501(c)(1) of the ADA makes clear that, as long
as the underwriting policies of an insurance company are consistent with state
law and based on sound actuarial data, they will not be subject to regulation
under the ADA. This applies to both health insurance and life insurance. In this
setting, the ADA does not prohibit discrimination, it only prohibits unfair or
arbitrary discrimination.
Fedder, supra note 5, at 579-80 (footnotes omitted).
35. 42 U.S.C. §§ 121.01 - 12213 (2000). The ADA is divided into four titles: Titles I
and V cover employment; Title II covers public services; Title IlI covers public
accommodations; and Title IV covers communications. Id.
36. Id. § 12111(8) (2000).
37. Id. § 1.2102(2) (2000).
3& See Sutton v. United Air Lines, Inc., 527 U.S. 471,478 (1999).
39. See Oak Ridge National Laboratory, Genetics Privacy and Legislation, at
http://www.ornl.gov/hgmis/elsi/legislat.html (last visited Aug. 21, 2002). Symptomatic
disabilities are, in essence, expressed genetic disorders or more simply, disabilities. See id.
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conditions.""' In addition, the ADA allows employers to require an
employee to provide medical information that is "job related and
consistent with business necessity.,
41
Because the language of the ADA does not plainly include genetic
information and because no case of genetic discrimination has been
brought under the ADA to court, it is unknown whether the law will be
interpreted to include discrimination based on genetic make-up. 2 In
1995, the Equal Employment Opportunity Commission (EEOC) issued
an interpretation of the ADA that included its belief that discrimination
based on genetic predispositions equates to regarding individuals as
having a disability, and as such, those individuals fit within the third
prong of the definition of disability.43 However, EEOC interpretations
and policy guidances are not binding in court and do not have the same
legal effect as statutes or regulations."
In fact, the U.S. Supreme Court recently disregarded an EEOC
interpretation of the term disabled in another context, leading many to
wonder whether EEOC guidance on genetic discrimination would hold
any weight. 5 In Sutton v. United Air Lines, Inc.,46 the Court held that the
petitioners, who had severe myopia, were not disabled because they used
corrective lenses that brought their eyesight to 20/20 or better. 7
Conversely, the EEOC's position was that, when evaluating ADA
claims, individuals should be considered in their untreated state.4s In
40. Id. An unexpressed genetic condition is an asymptomatic genetic disorder and
occurs when an individual has a genetic marker for a condition but does not show any
symptoms or signs of that condition. See id.
41. Id.
42. See Congressional Research Service, supra note 24, at 10.
43. See id. at 8; see also EEOC Compliance Manual, Section 902, Definition of the
Term Disability, available at http://www.eeoc.gov/docs/902cm.html (last visited Apr. 20,
2002). The EEOC provided, "covered entities that discriminate against individuals on the
basis of such genetic information are regarding the individuals as having impairments that
substantially limit a major life activity. Those individuals, therefore, are covered by the
third part of the definition of 'disability."' Id.
44. See Oak Ridge National Laboratory, supra note 39 (citing the EEOC
interpretation of the ADA that was issued in March 1995).
45. See Sutton v. United Air Lines, Inc., 527 U.S. 471, 480 (1999); see also Miller,
supra note 13, at 241 (acknowledging that even though the EEOC takes the position that
the ADA protects individuals with unexpressed genetic conditions, the EEOC
Interpretive Guidance can only be used as persuasive authority because it "does not have
the same force of law as a federal statute or regulation" and that, as of yet, the EEOC
position has not been tested in the courts).
46. 527 U.S. 471 (1999).
47. Id. at 475.
48. Id. at 480.
2002]
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holding that "the determination of whether an individual is disabled
should be made with reference to measures that mitigate the individual's
impairment,"49 the Court effectively restricted the definition of who is an
individual with a disability.50 As to the petitioners' claim that they were
"regarded as" disabled, the Court answered:
There are two apparent ways in which individuals may fall
within this statutory definition: (1) a covered entity mistakenly
believes that a person has a physical impairment that
substantially limits one or more major life activities, or (2) a
covered entity mistakenly believes that an actual, nonlimiting
impairment substantially limits one or more major life activities.
In both cases, it is necessary that a covered entity entertain
misperceptions about the individual -- it must believe either
that one has a substantially limiting impairment that one does
not have or that one has a substantially limiting impairment
when, in fact, the impairment is not so limiting.5'
Thus, for a person with a genetic predisposition to bring suit successfully
under the ADA, he must prove that he either presently has a substantial
impairment or that he is mistaken to have a substantial impairment that
presently limits a major life activity.52
49. Id. at 475.
50. The Court's opinion effectively restricted the definition of disability by requiring
courts to evaluate plaintiffs after consideration of any mitigating or corrective measures.
See id. For example, the plaintiffs in Sutton had severe myopia, but because they wore
corrective lenses, the Court deemed them not disabled. See id. The Court stated:
For instance, under [EEOC Interpretive Guidance], courts would almost
certainly find all diabetics to be disabled, because if they failed to monitor their
blood sugar levels and administer insulin, they would almost certainly be
substantially limited in one or more major life activities. A diabetic whose illness
does not impair his or her daily activities would therefore be considered disabled
simply because he or she has diabetes. Thus, the guidelines approach would
create a system in which persons often must be treated as members of a group of
people with similar impairments, rather than as individuals. This is contrary to
both the letter and the spirit of the ADA.
Id. at 483-84.
51. Id. at 489.
52. 42 U.S.C. § 12102(2)(A),(C) (2000); see also Murphy v. United Parcel Service,
Inc., 527 U.S. 516 (1999). Murphy was one of three cases decided by the Supreme Court in
1999 that addressed the definition of disability. Id.; see also Albertson's Inc. v.
Kirkingburg, 527 U.S. 555 (1999); Sutton v. United Air Lines, Inc., 527 U.S. 471 (1999). In
Murphy, the Court directly focused on the "regarded as" prong of disability and found
that the plaintiff was not regarded as substantially limited in the major life activity of
working. Murphy, 527 U.S. at 521-24. In short, Murphy illustrates that "making the case
that one is regarded as substantially limited in a major life activity, particularly the major
life activity of working, is likely to be difficult." See Congressional Research Service, supra
note 24, at 13.
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The Court emphasized that the definition of "substantially limits"
requires that a person "be presently - not potentially or hypothetically -
substantially limited in order to demonstrate a disability."53 The Sutton
Court, however, did not define what constituted a major life activity. It is
clear that its restrictive definition of disabled and its narrow
interpretation of being "regarded as" being disabled, as it relates to a
major life activity, pose a hurdle for potential genetic discrimination
plaintiffs.M
Conversely, in another ADA case, Bragdon v. Abbott,55 the Supreme
Court held that the plaintiff's HIV was a covered disability.
Specifically, the Court stated that asymptomatic HIV is a physical
impairment "from the moment of infection" because of "the immediacy
with which the virus begins to damage the infected person's white blood
cells and the severity of the disease."57 In support of the Court's opinion,
EEOC Commissioner Miller stated that "[t]he reasoning underlying the
Bragdon decision supports the application of the ADA to individuals
with asymptomatic genetic disorders and genetic predispositions.""
However, the Court found that Bragdon's HIV substantially limited her
ability to reproduce because of the fear of passing on the infection. 9 An
asymptomatic genetic defect - even if it is found to be an impairment -
presently does not adversely affect any major life activities the way
asymptomatic HIV does.6°
53. Sutton, 527 U.S. at 482.
54. See id. at 492 (declining to determine the validity of the EEOC regulation
classifying working as a major life activity but noting that "there may be some conceptual
difficulty in defining 'major life activities' to include work"); see also Congressional
Research Service, supra note 24, at 11 (concluding that the reasoning used by the Court in
Sutton "appears to make it unlikely that an ADA claim based on genetic discrimination
would be successful").
55. 524 U.S. 624 (1998).
56. Id. at 630-47.
57. Id. at 637.
58. Miller, supra note 13, at 243.
59. 524 U.S. at 637-42 (describing the process by which HIV causes immediate
abnormalities in a person's blood and tissues, and concluding that persons infected with
HIV are substantially limited in their ability to reproduce, considered by the Court to be a
"major life activity," because there is virtually no way to prevent the disease from being
passed on to offspring).
60. An asymptomatic individual is described as one who has an increased risk for
disease but no symptoms of that disease. See Michael S. Yesley, Prohibitions of Genetic
Discrimination Should Be Fine-Tuned, Mar. 1, 2001, at http://www.geneletter.com/03-01-
01/features/pm discrimination.html. There is no guarantee that a person's asymptomatic
genetic defect will ever become symptomatic, whereas a person with asymptomatic HIV
risks developing full-blown AIDS and passing on the disease through reproduction.
Furthermore, not all genetic defects are inheritable. See Steve Lebau, Genetic Testing.
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The holding of Bragdon should be taken with caution, however,
because three dissenting Justices signaled how they may rule if the issue
61of genetic discrimination under the ADA were to arise. In asserting
that reproduction is not a major life activity, Chief Justice Rehnquist
stated in his dissent:
Asymptomatic HIV does not presently limit respondent's
ability to perform any of the tasks necessary to bear or raise a
child. Respondent's argument, taken to its logical extreme,
would render every individual with a genetic marker for some
debilitating disease 'disabled' here and now because of some
possible future effects. 2
The Court's reading of disabled in Sutton and the subtle glimpse
provided by the dissent in Bragdon signal that the ADA is likely to
provide little, if any, protection for cases of genetic discrimination and
that therefore, potential plaintiffs must look elsewhere should they
decide to bring a claim.63
Balancing Benefits and Abuses, USA TODAY MAGAZINE, July, 2000 (noting that the
dilemma lies with the fact that genetic tests only predict a probability that an individual
will contract a disease in the future and that tests merely show a predisposition toward
disability, not a guarantee that the person will develop that disability), available at
http://www.findarticles.comlcfdls/m272/2662_129/63668117/ print.jhtml (last visited July
26, 2001). EEOC Commissioner Miller articulated a similar view:
Carriers do not themselves have a particular disease or disorder and may never
develop the disease or disorder, but they nevertheless possess recessive genes
and pass them along to their children in whom the disease or disorder might
occur. Possessing a faulty gene without more does not necessarily lead to the
realization of the disease or disorder. A variety of factors influence the gene's
penetrance and the chances one will actually develop symptoms.
Miller, supra note 13, at 229. Furthermore, while there are certain disorders for which
genetic testing is highly accurate and predictive (Huntington's disease, for example), there
are other diseases such as breast cancer, cystic fibrosis, and Alzheimer's for which the
individual's chances of contracting the disease are largely dictated by family history. See
id. at 230-31.
61. Bragdon, 524 U.S. at 661 (Rehnquist, C.J., dissenting, was joined by Justices
Scalia and Thomas) (noting that "[a]symptomatic HIV does not presently limit
respondent's ability to perform any of the tasks necessary to bear or raise a child"); see
also 106th Congress, HELP Hearing, supra note 11 (testimony of Paul Steven Miller)
(stating that "three members of the Supreme Court have already indicated their
reluctance to find individuals with genetic markers for debilitating diseases covered under
the ADA" and that Chief Justice Rehnquist's comments "raise the question whether the
justices would reject outright the ADA's protection of individuals with genetic markers").
62. 524 U.S. at 661.
63. See Congressional Research Service, supra note 24, at 13 (noting that the Court's
recent decisions "use reasoning that would make it unlikely that most ADA claims based
on genetic discrimination would be successful").
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B. One Step at a Time - The Health Insurance Portability and
Accountability Act of 1996 and Executive Order No. 13,145 Prohibiting
Discrimination in Federal Employment Based on Genetic Information
Currently, there are two federal statutes in existence that directly and
indirectly address the issue of genetic discrimination.' 4 In 1996, Congress
enacted the Health Insurance Portability and Accountability Act
(HIPAA),6' which applies only to employer-based and commercially
issued group health insurance.66 At the time, HIPAA was "far reaching
legislation designed to improve the portability of health coverage and to
provide other protections to recipients of health coverage." 67
This law bars the use of genetic information to deny health insurance
to people who change jobs, but it does not regulate new insurance
premiums.6 HIPAA prohibits group health plans from using genetic
information to deny or limit eligibility for coverage and from charging
individuals more for coverage based on their genetic information. 69 The
Act also defines and places limits on exclusions for pre-existing
conditions. 7° However, the Act does not prohibit insurers from requiring
or requesting genetic testing, nor does it require them to obtain
64. See id. at 4 (noting that there are no federal laws that "comprehensively address
the issues raised by the use of genetic information" but that HIPAA and the executive
order issued by President Clinton are the only federal laws that "directly addresses the
issue of discrimination based on genetic information"); see also Interagency Report, supra
note 15 ("A few protections exist incidentally under federal laws enacted to address other
types of workplace discrimination. The incidental federal protections against workplace
discrimination based on genetic information that do exist are narrow in scope and, in large
measure, not well established.").
65. 29 U.S.C. § 1181 (2000).
66. See, e.g., Oak Ridge National Laboratory, supra note 39 (noting that there is no
parallel law applying to private individuals seeking health insurance coverage in the
individual market).
67. Genetic Non-Discrimination: Implications for Employer Provided Health Care
Plans: Hearings on H.R. 602 Before the House Subcomrr on Employer-Employee
Relations, Comm on Educ. and the Workforce, 107th Cong. 80 (Sept. 6, 2001) [hereinafter
107th Congress, Sept. House Hearing] (testimony of Mary K. Williams, Attorney for
Alston & Bird), available at http://edworkforce.house.gov/hearings/107th/eer/eerhearings.
htm.
68. See Oak Ridge National Laboratory, DOE ELSI Program Emphasizes
Education, Privacy - A Retrospective (1990-2001), at http://www.ornl.gov/hgmis/resource/
elsiprog.htmi (last visited Aug. 27, 2002) (noting that if a health insurance policy shows
that an individual has a genetic condition, that person's insurance premium may be
prohibitively high).
69. See Oak Ridge National Laboratory, supra note 39 (identifying the major
premises of the HIPAA provisions covering genetics).
70. Id. (stating that HIPAA explicitly asserts that "genetic information in the absence
of a current diagnosis of illness shall not be considered a preexisting condition").
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authorization before disclosing this information." Furthermore, it does
not prevent lifetime caps on all or specific benefits for certain
conditions.
Pursuant to a provision in HIPAA that required supplemental
comprehensive privacy regulations by the Department of Health and
Human Services (HHS), in December 2000, HHS issued final regulations
on issues of privacy within HIPAA (Privacy Regulations).73 On July 6,
2001, HHS issued the first guidance on the Privacy Regulations in an
effort to clarify certain aspects.
74
The Privacy Regulations apply to any use and disclosure of individual
health information.75 They give individuals a right to access their own
medical records and to know who else has accessed them.76 The
regulations also impose strict requirements on health plan administrators
to secure and control access to employee health information.7   These
requirements include an obligation to provide adequate firewalls so that
employee health information is not shared with unauthorized personnel,
as well as training measures to ensure that all employees are informed
about "privacy protection policies and procedures, locking rooms that
71. See Congressional Research Service, supra note 24, at 5 (noting the exceptions in
HIPAA).
72. Id.
73. See 107th Congress, Sept. House Hearing, supra note 67, at 81 (testimony of Mary
K. Williams). HHS received and considered 52,000 comments after issuing proposed
privacy regulations in 1999, and it solicited another 24,000 comments in March 2001 in an
effort to understand the impact of the final regulations on employer-sponsored health
plans. See id. The regulation was mandated by Congress when it failed to pass any
comprehensive privacy legislation as required by HIPAA by 1999. See Oak Ridge
National Laboratory, supra note 39. The regulations call for the HHS Office of Civil
Rights to enforce their compliance. See U.S. Department of Health and Human Services,
HHS Announces Final Regulations Establishing First-Ever National Standards To Protect
Patients' Personal Medical Records, Dec. 20, 2000, at http://www.hhs.gov/news/press/
2000pres/20001220.html.
74. See 107th Congress, Sept. House Hearing, supra note 67, at 81 (testimony of Mary
K. Williams) (testifying that "[t]he changes to the Privacy Regulations over the last two
years as well as the clarifications issued since the final regulations were issued demonstrate
that. . .HHS has increased substantially [its] understanding of the administration of
employer-sponsored health plans").
75. See id. at 81 (describing the regulations as they relate to employer-sponsored
health plans).
76. See Oak Ridge National Laboratory, supra note 39 (describing patients' access to
their own records as one of the new standards created by the Privacy Regulations).
77. See 107th Congress, Sept. House Hearing, supra note 67, at 81 (testimony of Mary
K. Williams) (describing the administrative burdens that the Privacy Regulations imposed
on group health plan administrators).
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contain medical records, limiting access to computer files, and document
retention and destruction policies."78
The Privacy Regulations are not specific to genetics but instead are
sweeping regulations that govern all health information.79 It has been
noted that the HIS regulations impose "substantial administrative
burdens" in the name of privacy."" Yet, in the two years since the
regulations were issued, HHS has revised the regulations to allow health
plans to obtain certain information without being burdened by the
requirement of prior consent before disclosure."' The revised regulations
also allow for disclosure of health information in other, more
administrative, tasks.!
The HIPAA Privacy Regulations' unfavorable relationship with the
health care industry is not the only flaw associated with the 1996
legislation." By far, the biggest downfall with HIPAA is that it is
unmatched in the individual health insurance market." According to the
Congressional Research Service, HIPAA "has been hailed as taking
'important steps toward banning genetic discrimination in health
insurance' but has also been criticized as not going far enough."85
One step toward preventing genetic discrimination, or at least
providing a remedy for its occurrence, was taken on February 8, 2000
when President Clinton issued an Executive Order to prohibit genetic
discrimination by federal employers and others receiving federal
funding.i6 This order "[p]rohibits federal employers from requiring or
requesting genetic tests as a condition of being hired or receiving
benefits," evaluating an employer's ability to do his job, classifying
78. Id. (describing the measures taken by group health plans to ensure confidentiality
of patient records).
79. See Oak Ridge National Laboratory, supra note 39 (noting that the new Privacy
Regulation standards apply to all aspects of HIPAA, not just genetics issues).
80. See 107th Congress, Sept. House Hearing, supra note 67, at 80-82 (testimony of
Mary K. Williams) (noting that the consent standard was the result of two years of HHS
comments that ultimately resulted in the Privacy Regulations).
81. See id. at 82.
82. See id. These administrative tasks include "internal quality review, activities
relating to creation, renewal, or replacement of a contract of health insurance or excess
loss insurance, legal services, auditing functions and business planning." Id.
83. See id. (summarizing some flaws in HIPAA's Privacy Regulations).
84. See Oak Ridge National Laboratory, supra note 39 (emphasizing that HIPAA
only applies to employer-based and commercially issued health insurance plans).
85. Congressional Research Service, supra note 24, at 5 (citing to the statement of
Rep. Louise Slaughter Before the House Science Subcommittee on Technology, Hearing
on Technological Advance in Genetic Testing: Implications for the Future, Sept. 17, 1996).
86. See Exec. Order No. 13,145, 65 Fed. Reg. 6,877 (Feb. 10, 2000).
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employees based on genetic information, or denying any advancement or
promotion because of an individual's genetic predisposition."' The order
defines protected genetic information to include information about an
individual's or his or her family members' genetic tests or other family
medical history that reveals the occurrence of a medical condition,
disease, or disorder in family members.8
The order has several exceptions. 9 One allows employees who have
been given a conditional offer of employment to be asked about any
occurrence of disease or other medical condition consistent with other
disability laws, namely the Rehabilitation Act.' Another exception
allows employers to require genetic tests to monitor the effects of toxic
substances in the workplace, and a third allows department or agency
health offices to collect "protected genetic information" about
employees who use employer-provided genetic or health care services.9'
A fourth exception allows employers to request or require information if
a current condition could prevent an "employee from performing the
essential functions of the job, or where it is to be used exclusively to
determine whether further medical evaluation is needed to diagnose a
current disease. '" All four exceptions create gaps in a law that already
only provides coverage to a select population, generating a need for
more expansive legislation. 93
C. The Latest Federal Attempt: The Genetic Nondiscrimination in Health
Insurance and Employment Act of 2001
The Genetic Nondiscrimination in Health Insurance and Employment
Act of 2001, proposed in the 107th Congress, is an effort to provide the
87. See Oak Ridge National Laboratory, supra note 39 (outlining the major
provisions of the executive order).
88. See American Bar Association, Commission on Mental and Physical Disability
Law, Legislation & Regulations: A Selected Listing of Federal and State Actions Current as
of March 1, 2000,24 MENTAL & PHYS. Dis. L. REP. 323 (2000).
89. See id. (listing the exemptions to include conditional offers of employment and
requests for protected genetic information where the employee who uses the employer-
provided health care plan authorizes the employer to collect the genetic information).
90. See id.
91. See Equal Employment Opportunity Commission, Questions and Answers:
EEOC Policy Guidance on Executive Order 13,145 Prohibiting Discrimination in Federal
Employment Based on Genetic Information, available at http://www.eeoc.gov/docs/qanda-
genetic.html (last visited Aug. 20,2002).
92. Congressional Research Service, supra note 24, at 7.
93. See Goldberg, supra note 17, at 23-24 (stating that the "obvious limitation" of the
executive order is its scope of coverage, which leaves "millions" of workers without legal
protection).
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inclusive legal protection presently lacking in federal laws such as
HIPAA, the Executive Order, and arguably, the ADA.94 Introduced on
the same day by Senator Tom Daschle and Representative Louise
Slaughter, the proposed bill is the most recent attempt to enact federal
legislation to protect against genetic discrimination. 9
Written to bar discrimination based on protected genetic information
as it may apply to health insurance and employment, the bill both
amends current law and creates new law.96 There are many provisions
detailing the obtaining, disclosure, and use of genetic information97 as
well as definitions of what this information includes.98 There is also a
provision for remedies in each of the health insurance and employment
titles, should a violation occur. 99
Title I of the bill prohibits discrimination in health insurance. Its
provisions amend current federal laws and will be discussed and analyzed
here as a group, as the amendments are consistent within each section.i °
Similarly, the bill and this discussion cover the individual health
insurance market - a sector not included within HIPAA - because the
amendments to the Public Health Service Act include amendments to
both the group and individual markets.'
94. See id. (stating that federal legislation is necessary to provide basic protection
against genetic discrimination, while concluding that "despite numerous efforts over the
course of the past decade, legal protection remains inadequate.").
95. See Erin Heath, Zipping Up Genes Discrimination, NAT'L J., July 21, 2001,
available at 2001 WL 7182492. Senator Tom Daschle introduced a similar bill in the 106th
Congress, which failed by a 44-54 vote, and Representative Louise Slaughter has been
proposing adaptations of genetic discrimination bills into the U.S. House of
Representatives since 1995. Id.
96. See Genetic Nondiscrimination in Health Insurance and Employment Act of
2001, S. 318, 107th Cong. (2001) available at http://thomas.loc.gov (last visited Aug. 20,
2002). Title I prohibits discrimination in health insurance on the basis of protected genetic
information by amending the Employee Retirement Income Security Act of 1974
(ERISA), the Public Health Service Act (PHSA), the Internal Revenue Code of 1986
(IRS Code), and the Social Security Act (SSA). Id. §§ 101-104. Title II prohibits
discrimination in employment on the basis of protected genetic information, but it does
not amend any federal laws. Id. §§ 201-210; see also Genetic Nondiscrimination in Health
Insurance and Employment Act, H.R. 602, 107th Cong. (2001).
97. See, e.g., S. 318 § 203(a).
98. See, e.g., S. 318 § 201.
99. See S. 318 § 104(b)(1) (amending Title XVII of the Social Security Act); H.R. 602
§ 104(b)(1) (amending Title XVIII of the Social Security Act); see also S. 318 § 207
(outlining the civil actions); H.R. 602 § 207 (outlining the civil actions).
100. See generally S.318 §§ 101-104 (relating to amendments to ERISA, PHSA, IRS
Code, and SSA); H.R. 602 §§ 101-104 (same).
101. See S. 318 § 102 (amending provisions of the Public Service Act, 42 U.S.C. § 300 et
seq., concerning group health plans and individual health plans); H.R. 602 § 102 (same).
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Generally, the bill prohibits insurers from denying eligibility or
adjusting premiums based on a person's protected genetic information."
An insurer is also prohibited from requiring an individual, or a family
member of that individual, to undergo a genetic test; in addition, insurers
are not allowed to request, require, collect, or purchase any protected
genetic information."" Furthermore, insurers may not disclose any
protected genetic information they have in their records.'"
Finally, a private right of action is created for violations of this bill,
with legal remedies and equitable relief including attorneys' fees, the
costs of expert witnesses, and civil penalties. 5 In addition, state laws
102. See S. 318 § 101(a)(2); H.R. 602 § 101(a)(2). There are definitions of what may be
classified as genetic information, along with other specifying terms. See S.318 § 104(b)(1);
H.R.602 § 104(b)(1) (defining genetic information to include "information about genes,
gene products, or inherited characteristics that may derive from an individual or a family
member of such individual (including information about a request for, or the receipt of,
genetic services by such individual or family member of such individual). Protected
genetic information means information about an individual's or a family member's genetic
tests or information about the occurrence of a disease or disorder in such family members.
See S. 318 § 104(b)(1); H.R. 602 § 104(b)(1). Information about the sex or age of the
individual, about chemical, blood, or urine analyses (unless they are genetic tests), or
about physical exams (or "any other information that indicates the current health status of
the individual") are expressly excluded from the definition of protected genetic
information. See S. 318 § 104(b)(1); H.R. 602 § 104(b)(1). Family members are limited to
the spouse of an individual, the dependent children (including adopted children) of the
individual, and any other individuals related by blood to the individual, his or her spouse,
or dependent children. See S.318 § 104(b)(1); H.R.602 § 104(b)(1). Genetic services are
defined as any health services that are used to "obtain, assess, or interpret genetic
information for diagnostic and therapeutic purposes, and for genetic education and
counseling." S. 318 § 104(b)(1); HR. 602 § 104(b)(1). Finally, a genetic test is defined in
the Act as "the analysis of human DNA, RNA, chromosomes, proteins, or metabolites
that detect genotypes, mutations, or chromosomal changes." S. 318 § 104(b)(t); H.R. 602
§ 104(b)(1).
103. See S. 318 § 101(b) (outlining the prohibitions on the collection of genetic
information by insurers); H.R. 602 § 101(b) (same).
104. See S. 318 § 101(b); H.R. 602 § 101(b). Disclosures are forbidden to other
members of the same group health plan, other insurance agents, issuers or third party
administers, the Medical Information Bureau or "any other person that collects, compiles,
publishes, or otherwise disseminates insurance information," an individual's employer, or
any other person who may be specified by regulation. S. 318 § 101(b); H.R. 602 § 101(b).
There is an exception, however, that allows insurers to request or collect this information
if it is necessary to pay for genetic services. See S. 318 § 101(b); H.R. 602 § 101(b). The
information is limited to evidence that genetic services were performed, but the results
must not be disclosed. See S. 318 § 101(b); H.R. 602 § 101(b). An insurer may deny
payment if such evidence is not provided. See S. 318 § 101(b); H.R. 602 § 101(b).
Furthermore, disclosures between health care providers for the purpose of treating an
individual are exempted from a requirement that prior consent be obtained before
disclosure of any collected genetic information. See S. 318 § 101(b); H.R. 602 § 101(b).
105. See S. 318 § 104(b)(1) (describing the remedies available for violations); H.R. 602
§ 104(b)(1) (same).
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that offer more protection with respect to genetic information are not
superseded by this bill.1°6
Title II, relating to employment discrimination, is new and does not
amend any existing federal employment laws.i°7 The definitions included
in Title I of each bill are identical to the definitions in Title II of each bill
with respect to family member genetic services, genetic tests, and
protected genetic information)' 8 The bill makes it illegal for employers,
employment agencies, and labor organizations to "fail or refuse to hire or
to discharge any individual, or otherwise to discriminate against an
individual with respect to the compensation, terms, conditions, or
privileges of employment" based on that individual's protected geneticinformation.' °9
Similar to the provision for health insurance, an employer,
employment agency, or labor organization may not request, require,
collect or purchase any protected genetic information. " " However, an
106. See S. 318 § 104(b)(1) (stating that no state law will be superseded by the federal
law); H.R. 602 § 104(b)(1) (same).
107. See S. 318 §§ 203-206 (applying to employer practices, employment agency
practices, labor organization practices, and training programs); H.R. 602 §§ 202-205
(same).
108. See S. 318 §§ 201(2), (4)-(6); H.R. 602 §§ 201(2), (4)-(6); see also supra note 102
and accompanying text. Additionally, the terms "employee," "employer," "employment
agency," and "labor organization" are defined to have the meaning as such terms in Title
VII of the Civil Rights Act of 1964. See S. 318 § 201(1); H.R. 602 § 201(1); see also Civil
Rights Act of 1964, 42 U.S.C. § 2000e (2000). The terms "employee" and "employer" also
include the meanings given under section 717 of the Civil Rights Act of 1964, 42 U.S.C. §
2000e-16 (2000). See S. 318 § 201(1); H.R. 602 § 201(1). In the context of employment,
genetic monitoring is defined as:
the periodic examination of employees to evaluate acquired modifications to
their genetic material, such as chromosomal damage or evidence of increased
occurrence of mutations, that may have developed in the course of employment
due to exposure to toxic substances in the workplace, in order to identify,
evaluate, and respond to the effects of or control adverse environmental
exposures in the workplace.
S. 318 § 201(3); H.R. 602 § 201(3).
109. See S. 318 § 203(a)(1) (describing the employment processes prohibited); H.R.
602 § 203(a)(1) (same). This bill also makes it illegal to limit, segregate, or otherwise
classify employees in any way that would deprive them of employment opportunities or
would adversely affect their status as employees because of protected genetic material.
See S. 318 § 203(a)(2); H.R. 602 § 203(a)(2).
110. See S. 318 § 203(a)(3) (describing the ban on collection or purchase of an
employee's genetic information); H.R. 602 § 203(a)(3) (same). There is an exception
where the employee has provided prior consent or the information obtained from a test is
used for genetic monitoring of biological effects of toxic substances in the workplace. See
S. 318 § 203(a)(3)(A)(i); H.R. 602 § 202(a)(3)(A)(i). In that situation, the employee must
receive the results only in a manner that ensures that the identity of specific employees is
not disclosed. See S. 318 § 203(a)(3)(A)(iv); H.R. 602 § 202(a)(3)(A)(iv).
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employer may request, require, collect, or purchase protected genetic
information in cases where it has extended a conditional offer of
employment to an employee."1 Any request or requirement must be
consistent with the provisions of the ADA and the Rehabilitation Act.'
2
With the proposed legislation, when an employer has extended a
conditional offer of employment, medical information may be used solely
to assess whether the applicant is able to perform the "essential
functions" for which the person applied."
3
If an employer does possess any protected genetic information, there
are provisions in the proposed legislation governing its maintenance."'4
All information must be treated and preserved as a part of the
111. See S. 318 § 203(a)(3)(C) (describing the exemption from the rule against
collection or purchase of genetic information for cases of conditional offers of
employment).
112. See id. § 203(a)(3)(C)(i) (mandating compliance with the ADA and the
Rehabilitation Act). The ADA has an absolute prohibition on any medical inquiries or
examinations at the pre-offer stage of employment. 42 U.S.C. § 12112(d)(2)(A) (2000).
Only after an employer has extended a conditional offer of employment - but before that
individual has begun work - may the employer obtain extensive medical information
about the individual, including genetic information. See id. § 12112(d)(3). In essence, the
employer may condition employment on the individual's successful completion of a
medical exam. See id. An employer may only revoke a conditional offer of employment if
the results reveal that the individual will not be able to perform the essential functions of
the job, with or without reasonable accommodation. Id. Post-hiring rules differ, however,
as employers are allowed to require employees to submit to medical exams if the employer
can demonstrate that the information gained from such a test is "job-related and
consistent with business necessity." Id. § 12112(b)(4)(A). The EEOC has interpreted this
standard to relate to employees' present ability to perform the job. See EEOC
Enforcement Guidance. Disability-Related Inquiries and Medical Examinations of
Employees Under the Americans with Disabilities Act (ADA), July 27, 2000, available at
http://www.eeoc.gov/docs/guidance-inquiries.html. In 1998, a plaintiff brought suit against
her employer, a government-funded research institution, to challenge the employer's
routine practice of testing for syphilis, pregnancy, and sickle cell traits. See generally
Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260, 1264 (9th Cir. 1998).
Alleging that the testing was done during mandatory medical exams but without the
plaintiffs knowledge or consent, the Ninth Circuit found that the employer had no basis
for performing these tests on employees like the plaintiff, who was employed in a clerical
position. See id. at 1275. However, it is important to note that the suit was not won on the
ADA claim because the court found that no adverse employment action was taken as a
result of the tests. See id.
113. See S. 318 § 203(a)(3)(C)(ii)(ll) (describing the type of information that may be
requested after a conditional offer of employment has been extended).
114. See S. 318 § 207(a) (stating the requirements with which the employer must
comply regarding any genetic information it has in its possession); H.R. 602 § 207(a)
(same).
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employee's confidential medical records."5 An employer shall not
disclose this information to anyone except: the individual whose genetic
information it has; occupational or health researchers conducting
research; a federal court when ordered to comply with a legal
proceeding; or government officials performing an investigation under
the act. "6
Title II of the proposed legislation also contains enforcement
provisions and a private right of action." ' Individuals aggrieved by a
violation of the bill may bring an action in either federal or state court.1
8
The bill specifies that the EEOC shall have the power and authority to
enforce Title II and may promulgate regulations to execute these
powers." 9 However, there is no requirement in the Senate version of the
legislation that individuals exhaust administrative remedies with the
EEOC before commencing a suit in court, unless an individual has
chosen to file charges of discrimination with the EEOC.' ° Courts may
award "any appropriate legal or equitable relief," which may include
attorneys' fees and the costs of obtaining expert witnesses. 2' Similar to
Title I on health insurance, Title II provides that the new law shall not
supersede any state law that offers employees more protection.
122
Today, individuals who have been discriminated against on the basis of
their genetic make-up have recourse in two federal laws, with a third bill
pending in Congress. However, the group of people covered by the first
two laws is limited to federal employees and participants in group health
insurance plans. This leaves a large majority of the population without
any legal protection from genetic discrimination. It is this group of
individuals, along with those already covered, who should be most
anxious for the pending legislation to be given serious consideration.
115. See S. 318 § 207(a) (stating that if an employer possesses genetic information
about an employee, the information should be kept as part of the employee's confidential
records); H.R. 602 § 206(a) (same).
116. See S. 318 § 207(b) (listing the exemptions to the rule of the maintenance of
genetic information by the employer); H.R. 602 § 207(b)(3) (same).
117. See S. 318 § 208 (describing the remedies available); H.R. 602 § 207 (same).
118. See S. 318 § 208(a); H.R. 602 § 207(a).
119. See S. 318 § 208(b)(1) (stating the authority of the EEOC to regulate the
legislation); H.R. 602 § 207(b)(1) (same).
120. S. 318 § 208(b)(2) (noting the absence of a requirement to file charges with the
EEOC).
121. See S. 318 § 208(c) (describing the relief available for violations); H.R. 602 §
207(c) (same).
122. See S. 318 § 209(3) (reiterating that no state law shall be superseded by the
federal legislation); H.R. 602 § 208(3) (same).
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II. GENETIC NONDISCRIMINATION LEGISLATION- GOING TOO FAR OR
NOT GOING FAR ENOUGH?
A. Limitations of the Existing Federal Statutes and Case Law
Should a case of genetic discrimination based on a predisposition be
heard before the current Supreme Court, it is likely Chief Justice
Rehnquist, along with Justices Scalia and Thomas (who joined the
Rehnquist dissent in Bragdon), would hold that a genetic predisposition
does not substantially limit any major life activities and thus is not a
disability under the ADA.' 3  In Bragdon, the Court held that
reproduction was a major life activity and that plaintiff's HIV infection
imposed a substantial limitation on that activity; thus, the plaintiff's HIV
was labeled a disability. 4
It is possible to draw analogies between the plaintiff in Bragdon and a
person with an asymptomatic genetic predisposition because
reproduction may be impaired if the genetic disorder is inheritable.'2
The Court made it clear that "the disability definition does not turn on
personal choice. When significant limitations result from the
impairment, the definition is met even if the difficulties are not
insurmountable."'26 One can infer from Bragdon that if individuals can
prove to the Court that their genetic conditions impair their ability to
reproduce, they would be deemed disabled and covered by the ADA. 27
123. See Miller, supra note 13, at 244-45 (noting that Chief Justice Rehnquist rejected
the argument that "a person's ability to reproduce is limited because the fatal nature of
HIV infection decreases the likelihood that the parent could survive to raise and nurture
the child to adulthood"); see also Bragdon v. Abbott, 524 U.S. 624, 661 (1998) (Rehnquist,
C.J., concurring in part and dissenting in part). Chief Justice Rehnquist argued:
Asymptomatic HIV does not presently limit respondent's ability to perform any
of the tasks necessary to bear or raise a child. Respondent's argument, taken to
its logical extreme, would render every individual with a genetic marker for some
debilitating disease "disabled" here and now because of some possible future
effects.
Id.
124. Bragdon, 524 U.S. at 639.
125. See Miller, supra note 13, at 243-44 (concluding that Bragdon supports the
argument that if a genetic condition is inheritable, the impairment would limit the
individual's ability to reproduce the same way it did for Bragdon); see also Congressional
Research Service, supra note 24, at 12 (noting that the definitional language in Sutton and
Bragdon could be contrasted with circumstances in which genetic defects do not ever
manifest).
126. Bragdon, 524 U.S. at 641.
127. See id. The Court in Bragdon held that conception and childbirth, while not
impossible for an HIV-infected person, are "dangerous to the public health" and therefore
meet the definition of a substantial limitation. Id.
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However, potential plaintiffs may be required to prove to the Court
that their genetic predispositions actually limit their ability to reproduce
(by presenting the possibility of passing their disease to offspring) and
that such genetic markers substantially limit other life activities besides
reproduction.'8 Despite the holding in Bragdon, three dissenters
expressed their view that reproduction is not a major life activity.' 29 They
also stated that each disability inquiry will be based on the particular
individual before the Court.' 3  Potentially, one person may be
substantially limited in his or her reproductive ability and another person
may be found not to be so limited. In Sutton, the Court made it clear
that not just anyone will be considered disabled and afforded the
protections of the ADA."' As a result, individuals looking to the high
court for redress for genetic discrimination are coming to the realization
that winning under the ADA is becoming more difficult, if not
impossible. Plaintiffs clearly need a more reliable legal shield with which
to fight instances of genetic discrimination.
3 2
HIPAA and President Clinton's executive order, the two federal
efforts that currently provide some protection in cases of genetic
discrimination, are not adequate because they are limited in scope.'33
Thus, they do not eliminate the need for a wide-reaching federal
nondiscrimination law addressing the specific concerns that genetics
present. 34  Both HIPAA and the executive order have serious
128. See id. at 638. The Court confined its decision to the issue of whether
reproduction was a major life activity, stating that "[i]t is our practice to decide cases on
the grounds raised and considered in the Court of Appeals and included in the question on
which we granted certiorari." Id.
129. Id. at 659 (Rehnquist, C.J., concurring in part and dissenting in part) (stating that
aside from the particular facts of Bragdon, the Court was "simply wrong in concluding as a
general matter that reproduction is a 'major life activity"').
130. Id. at 657 (Rehnquist, C.J., concurring in part and dissenting in part) (noting that
the ADA could not be clearer on this point, stating that the disability determination must
be made "with respect to an individual"); see also 42 U.S.C. § 12102(2) (2000).
131. See Sutton v. United Air Lines, Inc., 527 U.S. 471, 482-83 (1999) (concluding that
individuals must be evaluated in their mitigated state in order to be deemed disabled).
132. See Congressional Research Service, supra note 24, at 13 (theorizing that
"[a]lthough an argument could be made that the ADA would cover individuals with
genetic defects in certain cases, the Court's most recent decisions, particularly Sutton and
Murphy, use reasoning that would make it unlikely that most ADA claims based on
genetic discrimination would be successful").
133. See Miller, supra note 13, at 255 (stating that the major pitfall of HIPAA is that it
does not cover the individual insurance market); Goldberg, supra note 17, at 23-24 (noting
that the obvious limitation of the executive order is the class of people it covers).
134. See Goldberg, supra note 17, at 23-25 (concluding that federal legislation is
necessary and surveying the pitfalls of existing federal law that could possibly cover
genetics legislation).
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deficiencies. 35 The reality of the executive order is that it only provides
protection to a small percentage of the working population - federal
workers.' 3  While it provides protection for federal employees, it
excludes the rest of working America, a large number of individuals who
continue to be subjected to invidious discrimination based on their
genes. 37 Additionally, executive orders may be revoked by succeeding
presidents, leaving no guarantee that the legal protection offered by the
order is permanent. HIPAA, while it does much for health care
generally, does little for cases of genetic discrimination because it does
not apply to every individual.
39
While the ADA, HIPAA, and the executive order may act as
deterrents to real cases of genetic discrimination, the reality remains that
the coverage these laws provide is questionable at best during a time
when medical science is rapidly evolving."" Furthermore, of the number
of states that have enacted genetics legislation, most limit their coverage
to health insurance and employment, or to one exclusively. 141 Currently,
adequate protection against genetic discrimination, which can be
encountered in day-to-day activities, is lacking on both the federal and
state levels. 41
B. Attempting To Fill in the Gaps: The Genetic Nondiscrimination in
Health Insurance and Employment Act of 2001
In March 2001, two bills were introduced into Congress in an attempt
to have the federal government finally legislate genetic discrimination,
specifically when it occurs with regard to health insurance plans and
135. See id. at 23-24.
136. See id. (writing that this restriction leaves millions of workers who are not federal
employees without protection).
137. See Oak Ridge National Laboratory, supra note 68 (noting that the executive
order does not affect most of the private sector).
138. See generally WILLIAM F. Fox, JR., UNDERSTANDING ADMINISTRATIVE LAW
69-70 (4th ed. 2000) (noting that executive orders do not have the force and effect of law,
but that they are "compelling documents that agencies ignore at their peril").
139. See Goldberg, supra note 17, at 22-25 (listing the advantages of the Privacy
Regulations to include recordkeeping improvement; stricter requirements for patient
consent; and provisions allowing for both civil and criminal penalties for entities that
misuse health information, but ultimately concluding that HIPAA is too limited in scope).
140. See Miller, supra note 13, at 259, 263 (stating that while there are laws on the state
and federal levels that explicitly prohibit genetic discrimination in some circumstances,
they do not provide workers with enough coverage).
141. id. at 259-63 (surveying state legislation in twenty-four states with genetic anti-
discrimination laws).
142. See generally Patrinos & Drell, supra note 4, at 8-10.
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employment decisions.143 While there are proponents and opponents of
the legislation, both within Congress and among the various groups who
would be affected by it, there is a general consensus that genetic
discrimination is a potential problem and that some legislation may be
needed. IM What form it should take is the subject of great debate.1 45
1. Arguments Against Genetic Nondiscrimination Legislation:
Redundancy and Conflict With Current Federal Law
Many believe that the proposed Genetic Nondiscrimination in Health
Insurance and Employment Act is unnecessary and would create a
conflict with existing federal laws.'4 The EEOC believes that the ADA
covers people with genetic predispositions who are discriminated against
on that basis in employment, but it supports the legislation given recent
Supreme Court treatment of disability cases. 47 Some admit the clearest,
though not the easiest, option would be to amend the ADA.
4
'
143. See generally Genetic Nondiscrimination in Health Insurance and Employment
Act, S.318 and H.R. 612, 107th Cong. (2001) available at http://thomas.loc.gov (last visited
Sept. 5, 2001).
144. See Daschle Genetic Discrimination Bill Would Hurt ADA, Civil Rights, 44 BLUE
SHEET 7, available at 2001 WL 7811530 (quoting the testimony of Senator Michael Enzi of
Wyoming and Washington, D.C.-based advocacy group LPA at the Senate Health
Education, Labor and Pensions Committee hearing on July 25, 2001 regarding proposed
federal genetic nondiscrimination legislation); see also Heath, supra note 95 (reporting the
concerns of employers and the support federal legislation has received from members of
the genetics community); Genetic Discrimination Legislation May Move in Senate This
Summer, 44 BLUE SHEET 29, available at 2001 WL 7811487 (noting that although H.R. 602
has been met with strong support, the measure has also been delayed in the past by GOP
leaders who oppose the bill); Goldberg, supra note 17, at 19 (reporting that "[m]any
lawmakers believe that potential harm specifically resulting from the misuse of genetic
information is so great that legal protection is required").
145. See, e.g., Genetic Discrimination Legislation May Move in Senate This Summer,
supra note 144 (commenting that Celera Genomics President and Chief Scientific Officer
Craig Venter would support the legislation, but that he has concerns regarding insurance
price controls).
146. See Daschle Genetic Discrimination Bill Would Hurt ADA, Civil Rights, supra
note 144 (reporting the fear of some members of Congress that a new federal genetic
nondiscrimination law would conflict with existing federal civil rights laws and the belief
that this topic is already regulated).
147. See Goldberg, supra note 17, at 24 (illustrating the EEOC view that genetic
disorders are covered by the ADA by discussing the hypothetical example of a case
described in an EEOC guidance on the topic).
148. See Genetic Nondiscrimination: Implications for Employers and Employees:
Hearings on H.R. 602 Before the House Subcomm. On Employer-Employee Relations,
Comm On Educ. and the Workforce, 107th Cong. (2001) [hereinafter 107th Congress, July
House Hearing] (testimony of Harold P. Coxson, Esq. on behalf of the Genetic
Information Nondiscrimination in Employment (GINE) Coalition), available at
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Still others believe the ADA actually covers genetic testing under the
provisions dealing with medical inquiries and examinations and that re-
legislating the issue under the guise of genetics adds redundancy to the
law.'49 Arguably, a genetic test is a medical exam because it is a tool that
can be used to determine the ability of an employee to perform job-
related functions.'O The ADA has rules regarding when an employer
may inquire about a disability or require that an individual submit to a
medical examination, as noted above."' These rules specify what is
allowed at the pre-offer, pre-employment, and post-offer stages of
employment. 152  It is questionable whether a genetic test would comply
http://edworkforce.house.gov/hearings/l07th/eer/eerhearings.htm. Coxson stated in his
testimony:
[M]embers of this Committee certainly are aware of how difficult it can be to
"open up" controversial labor and employment laws to amendment even decades
after enactment, based on fears of the law's original proponents that such
amendments will be outside of their control. We are aware of the fact that
proposals to amend the ADA may raise such fears, although a simple, straight-
forward ADA amendment would be the most direct way of addressing this issue.
With reference to any genetic nondiscrimination legislation, we would suggest
that one way to alleviate such fears, while avoiding "genetic exceptionalism,"
would be to incorporate ADA principles in a free-standing genetic
nondiscrimination bill; and, one way to avoid the risk of legislation which
becomes out-dated "before the ink is dry" is to mandate Congressional review or
study of the legislation within a few years of its enactment.
Id. at 75-76.
149. See id. at 80 (testimony of Harold Coxson) (arguing that an employer is already
limited by the ADA from engaging in genetic testing and using the results to make
employment decisions).
150. See id. (testimony of Harold Coxson). Coxson states that "[g]enetic testing is a
medical examination and the ADA contains specific provisions limiting. . . medical
examinations and inquiries." Id. at 80. Permissible medical exams and inquires during the
employment stage are defined at 42 U.S.C. § 12112(d)(4)(B) (2000) to be "voluntary
medical examinations, including voluntary medical histories, which are part of an
employee health program available to employees at that work site. A covered entity may
make inquiries into the ability of an employee to perform job-related functions."
Furthermore,
[a] covered entity shall not require a medical examination and shall not make
inquiries of an employee as to whether such employee is an individual with a
disability or as to the nature or severity of the disability, unless such examination
or inquiry is shown to be job-related and consistent with business necessity.
42 U.S.C. § 121,12(d)(4)(A) (2000).
151. See supra note 112 and accompanying text (describing what the ADA allows for
medical inquiries and exams at the different stages of employment).
152. See 42 U.S.C. § 12112(d)(3) (2000) (allowing an employer to condition an offer
upon the completion of a medical exam); see also 107th Congress, July House Hearing,
supra note 148, at 81 (testimony of Harold Coxson) (noting that the conditional offer
medical exam as provided in the ADA contains no limitations on the scope of the exam
and concluding that the ADA would not bar an employer from engaging in genetic testing
at that stage of the employment process); cf 42 U.S.C. § 12112(d)(3)(A)-(C) (2000)
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with the "job-related and consistent with business necessity" standard of
the ADA because genetic markers may have no present impact on an
individual's ability to perform job-related functions. 153
Legislators have attempted to resolve this uncertainty with the
proposed legislation."' The bill allows employers to request, require,
collect, or purchase genetic information only if the request or
requirement is consistent with the ADA.155 This language, however, may
not be a sufficient safeguard because employers may easily prove that the
exam they administered was "job-related and consistent with business
necessity," and it remains to be determined how best to distinguish
genetic from non-genetic information.1 56  In addition, the provision
(listing the three requirements the employer must satisfy in order to give a medical exam:
"all entering employees are subjected to such an examination regardless of disability; the
information obtained regarding the medical condition or history of the applicant is
collected and maintained in separate forms and files and is treated as a confidential
medical record;" and the results of the exam are to be used only in accordance with the
requirements of the statute). In addition, the ADA limits use of the information obtained
through these exams and inquiries to deny employment only if it can be shown that they
were "job-related and consistent with business necessity." See id. § 12112(d)(4)(A); see
also 29 C.F.R. § 1630.10 (stating that there should be a fit between job criteria and an
individual's ability to do the job); 106th Congress, HELP Hearing, supra note 11
(testimony of EEOC Commissioner Paul Steven Miller) (noting that during the
conditional offer stage of employment, "the ADA may not prohibit an employer from, for
example, obtaining genetic information of job applicants, requiring genetic screening as a
condition of employment or purchasing genetic information about applicants from a
genetic information data bank").
153. See 107th Congress, July House Hearing, supra note 148 (testimony of Harold
Coxson). Coxson stated:
The current trend of judicial decisions recognizes that non-disabled individuals
may enforce the statute's restrictions on medical inquiries. Hence, even if an
individual with a genetic marker or defect is not deemed to be "disabled" within
the definition of the ADA, the statute still protects the person from being
required to undergo genetic testing unless the testing complies with the above
requirements.
Id. at 82 (footnotes omitted). For a discussion of these requirements, see supra note 147.
154. See generally Genetic Nondiscrimination in Health Insurance and Employment
Act, S. 318 and H.R. 602, 107th Cong. (2001) available at http://thomas.loc.gov (last visited
Sept. 2, 2001).
155. See S. 318 § 203(a)(3)(C)(i) (describing the requirement that any request for
genetic information must comply with the ADA provisions on medical exams and
inquiries).
156. See generally Lainie Friedman Ross, Genetic Exceptionalism vs. Paradigm Shift.
Lessons From HIV, 29 J. L. MED. & ETHICS 141, 142-44 (2001) (surveying the work of an
ELSI task force that considered, and rejected, four arguments that would have classified
genetic information as fundamentally different from other medical information); see also
Fedder, supra note 5, at 577 (noting that anti-discrimination laws, while they impact on
privacy concerns, do not adequately protect privacy because the main focus of anti-
discrimination laws is to make sure genetic information is not used improperly, but the
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stating that a request or requirement for the purpose of determining
whether individuals have medical conditions or disorders that could
prevent them from performing essential job functions does not include
the critical language "with or without reasonable accommodation," -
which is included in the ADA provision.1 57  This omission could be
interpreted by a court to conflict with the ADA's established provision
regarding medical exams and conditional offers of employment.15
Opponents also believe the bill is both redundant and would subject
health insurance plans to conflicting federal laws.'59 Professionals in the
health insurance industry vehemently oppose the legislation, stating that
HIPAA already covers the issue."' They believe that HIPAA is "far-
reaching legislation designed to improve the portability of health
coverage and to provide other protections to recipients of health
coverage."'' It was believed that in enacting HIPAA, Congress had
recognized the importance of clear, nationally uniform standards for
health insurance."' When HIPAA set out to ban genetic discrimination
laws do not usually prohibit the collection of genetic information in the first place); cf
107th Congress, July House Hearing, supra note 148, at 39 (testimony of Cheye Calvo).
Calvo looks at this distinction from a policy approach:
The central policy issue is whether genetic information is special and requires
higher legal protections or whether it is simply another form of health
information and should be treated the same. The answer to this question largely
influences the policy approach. The ADA allows employers to condition job
offers on the completion of medical exams and conduct medical examinations
and inquiries on current employees that are "job-related and of business
necessity." Therefore, an inclusive approach to genetics employment policy,
based on the ADA, permits some degree of genetic testing. Genetic-specific
laws place greater restrictions on employers' use of genetic information, and may
include strict prohibitions on the use of genetic testing by employers.
Id. at 39.
157. See S. 318 § 203(a)(3)(C)(ii)(l1) (noting the absence of reasonable
accommodations in the definitional language). But cf 42 U.S.C. § 12111(8) (2000) (noting
that the definition of a qualified person with a disability is an "individual with a disability
who, with or without reasonable accommodations, can perform the essential functions of
the employment position that such individual holds or desires").
158. See Interagency Report, supra note 15 (surveying the ADA provisions on medical
inquiries and exams).
159. See 107th Congress, Sept. House Hearing, supra note 67, at 79-80, 82 (testimony
of Mary K. Williams) (testifying that current federal law already protects group health
plan participants from genetic discrimination).
160. See id. at 84 (testimony of Mary K. Williams) (testifying as to the current state of
the law for the health care industry, and concluding that "[n]o additional regulation in this
area of employee benefit law is needed to accomplish the objective of genetic non-
discrimination").
161. Id. at 80.
162- See id. at 79.
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in health insurance, it was in essence ensuring uniformity for individuals
across state lines. 163
Also, HIPAA's privacy rules protect the collection, use, and disclosure
of health plan participants' medical information, which includes genetic
information.' 6 HIPAA also prohibits employers from using any health
information that is received from a group health plan for any
employment-related decisions 6' Testifying before the House
Subcommittee on Employer-Employee Relations, Attorney Mary
Williams stated:
Because of the sweeping and comprehensive nature of
HIPAA's Privacy Regulations, it would be virtually impossible
to draft additional legislation governing health plans' use and
disclosure of medical information without including issues
already regulated by those Privacy Regulations. A multiplicity
of federal laws governing the same subject matter leads to a
complex and conflicting regulatory scheme creating confusion
for both regulated entities and consumers alike.' 66
By enacting the Genetic Nondiscrimination in Health Insurance and
Employment Act, Congress would essentially be re-regulating an already
regulated entity - group health plans.' 67 However, because HIPAA only
applies to group health plans, it may be necessary to revise HIPAA to
include non-group health plans as well. Still, there remains the chance
that the individuals seeking private health insurance may be at a greater
risk for discrimination. 6' It has been suggested that provisions covering
163. See id. (noting that when Congress enacted HIPAA, it recognized that "the only
way to establish clearly understood, workable and effective requirements for privacy and
non-discrimination in a health plan was to establish a nationally uniform standard with a
single enforcement scheme").
164. See id. at 79-80 (explaining that "[a]ny use or disclosure of genetic information for
purposes other than treatment, payment of a claim, or health care operations without
written authorization of the plan participant, is illegal" under HIPAA).
165. See id. at 81-82 (further explaining how HIPAA makes employment decisions
illegal if they are based on genetic information received from a health plan).
166. Id. at 82.
167. See id. (concluding that the health care industry is already regulated through
HIPAA, and that further regulation will only add confusion and cost to the system).
168. See id. at 71 (testimony of Jane Massey Licata, J.D., Ph.D.) (stating that coverage
should be expanded as fully as possible into the individual health insurance market).
Licata also stated that imposing considerable penalties for any knowing violation of the
Act may help protect potential victims of this type of discrimination. She stated:
Under the current scheme, the employee or insured, who may not have
reasonable access to legal representation, may not be able to effectively protect
their privacy interests. I would therefore suggest the Government take a more
proactive role and that there be substantial civil penalties provided for in the
event there is any violation.
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individual policies be strengthened to prevent that inequality from
occurring. 69
In addition, the insurance industry has concerns about the enforcement
of these laws. 7" HIPAA's Privacy Regulations are enforced by the HHS
Office of Civil Rights, while ERISA, which is amended under the new
legislation, falls under the "enforcement jurisdiction of the Department
of Labor." '171 Accordingly, Williams testified that "not only would
additional legislation subject health plans to conflicting federal laws, it
would subject group health plans to multiple and conflicting penalties
imposed by multiple regulatory agencies."' 72 Amending the current bill
to provide for this situation may prevent future conflicts, but it would
also likely make the business of offering health insurance that much
more difficult, as administrators would be forced to be extremely familiar
with all federal laws and the agencies enforcing them.73
Williams foresaw another unintended consequence if Congress were to
enact additional legislation with overly-broad language.'74 A law that is
drafted "without a complete comprehension of the operations of a group
health plan" will result in "burdensome requirements" that will drive
employers to decide not to even offer health plans to their employees.'75
Id.
169. See id. (testifying that while the proposed legislation goes a long way toward
protecting employees, one area that needs to be improved is the provisions relating to the
individual health insurance market).
170. See id. at 82 (testimony of Mary K. Williams) (noting the confusion that will result
if too many federal agencies are given the authority to enforce both HIPAA and genetic
non-discrimination legislation).
171. See id. (describing which agency would be responsible for enforcement of the
legislation).
172. Id.
173. Id. Williams further stated:
Allowing two regulatory agencies to enforce conflicting rules concerning the
same subject matter will result in exactly the situation that ERISA was meant to
correct. Employers that sponsor group health plans should have a single,
uniform framework where the penalties for wrongful use or disclosure of any
medical information, including genetic information, are clearly understood and
fairly applied. The HIPAA Privacy Regulations attempt to serve this purpose.
Id.
174. See id. at 83 (stating that "[any additional legislation in the medical information
area, especially if it includes language directed at genetic non-discrimination, must be
drafted very carefully to avoid unintended consequences that could negatively impact the
broader (and non-discriminatory) use of information for purposes that benefit group
health plan participants").
175. See id. Donald Young, Interim President of the Health Insurance Association of
America has said that "[i]t is becoming increasingly costly for our members to sort through
and comply with all these requirements, especially when an insurer does business in a
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Clearly, it will be necessary for Congress to take another look at the
exact language of the bill before moving forward, or it is sure to have the
insurance industry fighting them in what could be a "reprise of the
debate over the Patients' Bill of Rights," with no real support from labor
management.176
2. Arguments Against Genetic Nondiscrimination Legislation:
Inconsistency With Other Federal Civil Rights Legislation
Beyond those in the health insurance industry who oppose the Genetic
Nondiscrimination in Health Insurance and Employment Act for its
redundancy and potential conflict with existing laws, there are those who
oppose it for its lack of consistency with existing federal civil rights and
nondiscrimination laws.' 77 In Congress, some members condition their
support on the bill being amended to require exhaustion of
administrative remedies.'78 Senator Michael Enzi (R-Wyo.) stated during
a Senate HELP Committee meeting in July that "[i]t is difficult to see the
justification for allowing claimants of genetic discrimination to file suit
directly in court and thereby avoid the complaint process that claimants
of other basis of employment discrimination mrfst follow."'179 The U.S.
large number of states.... This cost ultimately is borne by consumers in the form of higher
premiums." See MacDonald, supra note 20, at Al; see also Genetic Discrimination
Legislation May Move in Senate This Summer, supra note 144 (reporting the written
statement of House Energy and Commerce Chair Billy Tauzin (R-La.), who urged
Congress to "take great care not to create an unnecessary bureaucracy that will chill the
collection and use of genetic information on behalf of patients and for research"). Many
believe regulating the use of genetic information is what is needed so that individuals do
not avoid getting a genetic test that could identify serious diseases. See 107th Congress,
HELP Hearing, supra note 7 (testimony of Kathleen Zeitz). Zeitz, a breast cancer
survivor with a family history of breast cancer and a daughter who refuses to be tested for
the identifiable BRCA1 or BRCA2 gene, testified that the potential for genetic
discrimination leads individuals to be afraid to share information with their health care
providers, to take advantage of genetic technologies, or to participate in genetic research.
See id.
176. See MacDonald, supra note 20 (reporting that insurers have stalled action "as
evidence has grown that the lack of federal rules on the use of genetic information is
hurting workers").
177. See Daschle Genetic Discrimination Bill Would Hurt ADA, Civil Rights, supra
note 144 (noting that there has been opposition to the bill in Congress by members who
believe its provisions are inconsistent with other nondiscrimination legislation).
17& See id. (reporting the views of Congressman Michael Enzi of Wyoming, who
opposes the bill because its failure to comply with administrative procedures that are part
of other federal laws puts it squarely in conflict with the federal civil rights laws).
179. Id.; see also 107th Congress, July House Hearing, supra note 148, at 41 (testimony
of Cheye Calvo, Senior Policy Specialist for the National Conference of State
Legislatures). Calvo testified that most state genetic discrimination laws provide the same
enforcement provisions as other anti-discrimination laws, noting that "[t]he primary
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Chamber of Commerce seems to agree that the proposed bill would
disrupt the settled dispute resolution procedures set in place with the
EEOC, stating that "[c]ontrary to every other employment
discrimination law, the bill permits unlimited compensatory and punitive
damages for discrimination based on genetic information....
Furthermore, the legislation permits victims of genetic discrimination
who may be asymptomatic, and thus not currently disabled, to receive
open-ended and uncapped damages beyond the damages available to
plaintiffs who were discriminated against because of a current non-
genetic-based disability.18 Some have labeled this possibility "genetic
exceptionalism""' because it gives genetics greater protection than other
discrimination claims such as race, gender, religion, national origin, or
183
age.
method of enforcement is through private rights of action, following an administrative
review and fact finding by the state agency or the EEOC." Id.
180. See Daschle Genetic Discrimination Bill Would Hurt ADA, Civil Rights, supra
note 144.
181. See Goldberg, supra note 17, at 26 (noting that open-ended liability in the
legislation permits victims of genetic discrimination to receive more damages than victims
of other discrimination claims based on race, gender, religion, national origin, or age).
182. See id. Genetic exceptionalism is the concept that "genetic information is so
fundamentally different from other health information that it must be given legal
protection distinct from other forms of medical information." Id.
183. See id.; see also 107th Congress, July House Hearing, supra note 148, at 39
(testimony of Cheye Calvo). Calvo testified that the central policy issue with genetic
nondiscrimination legislation is whether genetic information "is special and requires
higher legal protections or whether it is simply another form of health information and
should be treated the same." Id. Calvo went on to survey state law approaches, noting
that twenty-six states have taken the "exceptional" approach, while other states have
taken a more inclusive approach by incorporating genetics into current disability
protections. See id. at 40. In an article comparing the approach that HIV health policy
took to the one that genetics policy is currently debating, Lainie Friedman Ross considers
and dismisses four arguments in support of policies of genetic exceptionalism. See Ross,
supra note 156, at 141. The first argument supporting genetic exceptionalism is "that
genetics, unlike HIV, reveals information that is fundamentally unique, such that
exceptional policies will be necessary even after therapies are developed." Id. at 142.
Ross states such a policy has the potential to take on eugenic qualities but concludes that
this argument is not compelling because "discrimination and stigmatization exist as long as
there are differences" between individuals, regardless of whether those differences have a
genetic basis. Id. at 141-42. The second argument is that genetic information has wider
implications and can reveal more information than what HIV status can reveal. Id. Ross
concludes that this argument fails as well, because the problem is not unique to genetics,
and genetics only highlights the ethical, social, and legal issues that already exist. Id. at
142-43. Third, genetic information is immutable, meaning that "a genetic test only needs
to be done once in order for one's genetic status to be known forever," whereas an HIV
test and a person's HIV status may change over time depending on exposure and
susceptibility to infection. Id. at 143. Ross finds problems with this argument as well,
stating that mutations do occur and even if genetics were immutable, the current
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In addition, the bill is inconsistent with other anti-discrimination laws
because it does not contain a statute of limitations provision.1" Similarly,
there is no "safe harbor" provision to protect employers from liability for
unintentional violations, such as inadvertently receiving protected
genetic information through insurance claims or through unsolicited
conversations.'" Ultimately, these shortcomings leave employers and
labor organizations with no clear understanding of their obligations
under federal labor and employment laws.18' The bill loses credibility
because it lacks a statute of limitations and an available safe harbor
defense for employers."'
knowledge of the human genome, despite the rapid advances, remains incomplete. Id.
Finally, much genetic information is probabilistic, whereas HIV status is definitive. Id.
Ross concludes that even though this is the strongest argument, genetic information is not
always probabilistic, and HIV information is not always definitive. Problems of inaccuracy
in test results occur with both classifications. Id. According to Ross, "[i]f what makes
genetics exceptional is its probabilistic and ambiguous nature, this is a chronic problem in
medicine and not unique to genetics. As such, a genetic diagnosis of disease
predisposition is not so fundamentally different from a diagnosis of HIV seropositivity."
Id. (footnote omitted).
Ross further discusses the ELSI Task Force's findings considering the same question
about whether genetics should be treated as exceptional, and notes that the group
ultimately rejected three justifications for such a policy. Id. Those justifications included:
whether genetic information was sufficiently different from other health information
because of its "prophetic potential;" whether genetic information was sufficiently different
"because of its implications for other family members;" or whether genetic information
was sufficiently different "because of its potential to stigmatize and victimize." Id.
184. See 107th Congress, July House Hearing, supra note 148, at 86-87 (testimony of
Harold Coxson) (testifying that by omitting a statute of limitations, the legislation both
opens the door for excessive litigation and runs afoul of other federal nondiscrimination
laws, which require that a plaintiff bring an action or file a complaint within a set period of
time or be barred from bringing the claim at all).
185. See id. Coxson questions whether such an employer is "presumptively held
strictly liable for any adverse employment action even for cause or based on
performance." Id. at 87. He concludes:
Certainly in the eyes of a jury, and without the filter of an agency such as the
EEOC to screen non-meritorious charges, the employer will be hard pressed to
demonstrate that the information was not an unlawful factor in the employment
decision, especially a decision involving an individual with a life-threatening
genetic marker who is likely to evoke the sympathy of a jury.
Id.
186. See id. 87-88 (stating that an absence of clear delineations of obligations under the
proposed legislation, and other anti-discrimination laws, will lead to confusion and will
impede the administration and enforcement of the laws).
187. But see 42 U.S.C. § 12113(a) (2000) (listing defenses available to employers in the
ADA, which does not include a safe harbor defense). The ADA's statute of limitations
period is set by statute in 42 U.S.C. § 2000-5(e)(1) to be 180 days.
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Additionally, the proposed Act does not limit its applicability to
employers with fifteen or more employees, as the ADA does."" Small
companies with fewer resources and different concerns will be subject to
the same regulations as large companies that may have deeper pockets
and diverse interests. As a result, the Act would be inconsistent with
other federal anti-discrimination laws, such as the ADA, which apply
only to employers with more than fifteen employees. 89
The numerous inconsistencies this legislation presents - lack of
exhaustion of administrative remedies, uncapped damages, widespread
applicability, and the lack of a statute of limitations - are potentially fatal
flaws that could prevent it from ever passing a majority of Congress."0
Because there is no cap on damages in the proposed bill and no
requirement that a plaintiff file a complaint with the EEOC, this
legislation opens the door to endless litigation with large money awards
by sympathetic juries."' One advocacy group in Washington, D.C. warns
that the legislation will create even more litigation at a time when the
judicial system is already at its limits."2 Clearly, more attention is needed
if the proposed legislation is going to be consistent with - and ultimately
amended into - existing federal civil rights laws.
188. See 42 U.S.C. § 12111(5)(A) (2000). The ADA defines an employer as:
a person engaged in an industry affecting commerce who has 1.5 or more
employees for each working day in each of 20 or more calendar weeks in the
current or preceding calendar year, and any agent of such person, except that, for
two years following the effective date of this subchapter, an employer means a
person engaged in an industry affecting commerce who has 25 or more
employees for each working day in each of 20 or more calendar weeks in the
current or preceding year, and any agent of such person.
Id.
1.89. See 42 U.S.C. § 121l1(5)(A) (2000); supra note 183 and accompanying text.
190. See Daschle Genetic Discrimination Bill Would Hurt ADA, Civil Rights, supra
note 144 (stating that Representative Enzi and others in Congress are reluctant to support
the legislation because of their belief that it upsets the balance of existing federal civil
rights laws).
191. See 107th Congress, July House Hearing, supra note 148, at 87 (testimony of
Harold Coxson). Coxson related the fears of those in the labor and employment industry
by stating, "We are concerned that this legislation, with its overly broad definition of
genetic information and open-ended liability for unlimited compensatory and punitive
damages, may actually serve to foster litigation and workplace disputes." Id.
192. See Goldberg, supra note 17, at 26 (reporting the opinions of LRA, an advocacy
organization which represents human resources executives). By requiring claimants with
discrimination cases to file a complaint with an administrative agency like the EEOC
before filing an action in court, the rationale is that the agency will have the expertise to
handle the claim, and the court's docket will not unnecessarily be burdened. See Fox,
supra note 138, at 317-20 (discussing the exhaustion doctrine).
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3. Arguments Against Genetic Nondiscrimination Legislation: Drafting
Loopholes and Other Fatal Errors
Beyond the criticism that the proposed legislation conflicts with
current federal law, there are other more technical problems with the
bill.'93 These drafting oversights range from the way genetic information
is defined to a more serious drawback - the fact that this legislation only
applies to employment and health insurance, leaving no protection for
the numerous other areas where genetic discrimination can occur.194
Recent congressional hearings have focused on many aspects of the
bill, including the definitional language and, in particular, how this draft
differs from past versions in the way it defines genetic information. 95 As
drafted, the bill prohibits employers from "the mere receipt or possession
of protected information."' 96  One witness recently testified before
Congress:
A practical, real world concern among employers is whether
such broad proscriptions would trigger litigation based on mere
knowledge of an employee's family disease or disorder, which
may come to the employer's attention through unsolicited
genetic information in routine medical reports, leave requests,
or even through on-the-job or off-the-job social conversations,
newspaper obituaries, and the like, where family illnesses or
causes of death may be discussed. 17
193. See, e.g., 107th Congress, July House Hearing, supra note 148, at 87-88 (testimony
of Harold Coxson) (noting the definitional problems with the legislation).
194. See id. (testifying as to the definitional deficiencies); see also Patrinos & Drell,
supra note 4 (listing other areas where new developments in genetics may pose legal
issues).
195. See 107th Congress, July House Hearing, supra note 148, at 88 (testimony of
Harold Coxson) (pointing to the difference in definitional language between the version of
the legislation in the 106th Congress and the version before the 107th Congress).
196. See id. at 87-88 (testimony of Harold Coxson) (stating the GINE Coalition's
concern that the term "protected genetic information" is more inclusive than necessary
and may leave employers with few legal defenses). In past years, drafts of the genetic
nondiscrimination legislation used the term "predictive" genetic information, a term that
is "commonly used and well understood" in the medical community. Id.
197. Id. (testifying that overly broad definitions such as "protected genetic
information" could serve as the basis for litigation arising from any adverse employment
decision and that if an employer is faced with unlimited damages, it may be forced to settle
with employees in order to "avoid a potential run-away jury award"). Coxson continued
to state that "[t]he law then becomes a 'sword' for trial lawyers rather than a 'shield' for
employees. And under [the bill] as drafted, the litigation sword could potentially be
wielded in multiple forums based on information received from normative human
behavior - visiting the sick and consoling the bereaved - that our traditions, social mores,
and laws should encourage." Id. at 89.
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Furthermore, defining genetic information to be "protected" rather
than "predictive" undermines the significance of a subtle delineation
between genetic information and other health information, a distinction
with which scientists are still grappling.' 9 There are well-established
genetic markers and reliable diagnostic tests available today to help aid
in this understanding, but a clearer definition may be necessary to avoid
excessive litigation.' 99 Additionally, eliminating the exclusion of "other
information relevant to determining the current health status of the
individual" from the definition of protected genetic information would
lessen the chance that access to genetic information is inadvertently
obtained.2 °
There are other provisions in the bill dealing with exceptions that may
prove problematic."" One such exception, relating to Title I, allows
health insurance companies to refuse to pay for a genetic services claim if
the individual does not provide evidence that he or she actually had a
genetic service performed." In effect, this exception places the
individual in the difficult position of choosing to pay for the service
himself or risk disclosure by the company. 2°3 This problem may be
corrected with specific language inserted in Title I to clarify what would
be sufficient evidence to satisfy such a claim.' °4
The other flaws in the legislation lay less with what is currently
included and more with what is purposely excluded. Specifically, there is
an absence of findings usually present in anti-discrimination or civil
19& See 107th Congress, July House Hearing, supra note 148, at 40 (testimony of
Cheye Calvo) (concluding that as a result of this nuanced distinction, "laws must clearly
define the realm of protections").
199. See 107th Congress, Sept. House Hearing, supra note 67, at 70-71 (testimony of
Jane Massey Licata) (stating that it would be "especially troublesome" if the information
deemed "predictive genetic information" were used to make employment or insurance
decisions).
200. See id. at 71 (testimony of Jane Massey Licata) (noting her concern that leaving
out "other information relevant to determining the current health status of the individual"
from the definition of protected genetic information could prove counterproductive to the
goal of preventing misuse of private information).
201. Genetic Nondiscrimination in Health Insurance and Employment Act, S. 318,
107th Cong., § 102(a) (2001) (relating to the payment of claims for genetic services);
Genetic Nondiscrimination in Health Insurance and Employment Act, H.R. 602, 107th
Cong., § 102(a) (2001) (same).
202. See S. 318 § 102(a); H.R. 602 § 102(a).
203. See 107th Congress, Sept. House Hearing, supra note 67, at 71 (testimony of Jane
Massey Licata) (discussing the exception for information needed for payment of a claim).
204. See id. (testimony of Jane Massey Licata) (suggesting that a receipt from a
licensed laboratory or health professional would be sufficient to prove a genetic service
was performed).
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rights laws. 2°5 This absence may be due to the shortage of known court
cases charging genetic discrimination.2°6 Secondly, while there is a
limited applicability to collective bargaining agreements, the bill does not
include a provision regarding dispute resolution forums as an alternative
205. See, e.g., Americans with Disabilities Act of 1990, 42 U.S.C. § 12101-12213 (2000)
(recording the findings of Congress at the time that it enacted the ADA). This section of
the ADA includes findings that "historically, society has tended to isolate and segregate
individuals with disabilities, and, despite some improvements, such forms of discrimination
against individuals with disabilities continue to be a serious and pervasive social problem"
and that "unlike individuals who have experienced discrimination on the basis of race,
color, sex, national origin, religion, or age, individuals who have experienced
discrimination on the basis of disability have often had no legal recourse to redress such
discrimination." Id. at § 12101(a)(2), (4).
206. See Heath, Zipping Up Genes Discrimination, supra note 95, at 2346. Heath
relates critics' view that new federal legislation is unnecessary because "[t]or the most
part, we're not seeing any pattern of genetic discrimination." Id. (quoting Mark Hall,
professor of law and public health at Wake Forest University). Professor Hall further
stated, "It's difficult to craft legislation in advance of the problem arising, because you
don't fully know the dimensions of the problem." Id. But see U.S. Equal Employment
Opportunity Commission, EEOC Petitions Court To Ban Genetic Testing of Railroad
Workers in First EEOC Case Challenging Genetic Testing Under Americans With
Disabilities Act, (Feb. 9, 2001) (detailing the case of an employee who sued his employer,
Burlington Northern Santa Fe Railroad (BNSF), after the railroad required blood tests of
employees who filed claims for work-related injuries) at http://www.eeoc.gov/press/2-9-01-
c.html (last visited Aug. 28, 2002). The EEOC charged that BNSF employees were
neither told of the genetic testing, nor asked to consent to the test, and that employees
who refused to provide blood samples were threatened with losing their jobs. Id. The
EEOC suit was the first lawsuit to challenge genetic testing under the ADA. Id. Two
months after the EEOC suit commenced, BNSF admitted to testing certain employees for
genetic markers and agreed to settle the case with the EEOC. See U.S. Equal
Employment Opportunity Commission, EEOC Settles ADA Suit Against BNSF for
Genetic Bias, (April 18, 2001), at http://www.eeoc.gov/press/4-18-01.html (last visited Aug.
28, 2002). Under the settlement, BNSF agreed not to directly or indirectly require its
employees to submit to blood tests, analyze or evaluate any blood or gene test performed
or obtained before the settlement, or retaliate or threaten employees who opposed testing
or who otherwise participated in the EEOC suit. Id. Also, as a part of the agreement, the
EEOC may seek compensatory and punitive damages up to $300,000 for each BNSF
employee who was subjected to a genetic test or who was retaliated against for a refusal to
take a test. Id. Throughout the suit, the EEOC maintained that the genetic testing
conducted by BNSF was a clear violation of the ADA's provision on unlawful medical
exams. Id. BNSF spokesperson Richard Russack said that the company requested its
employees to undergo the tests because "'there could be a predisposition within the body
chemistry of the individual' to develop the carpal tunnel syndrome 'that had nothing to do
with work."' Scott Gottlieb, US. Employer Agrees To Stop Genetic Testing, BRITISH
MED. J. (Feb. 24, 2001) at http://www.findarticles.com/ef_0/m0999/7284_322/71820699/
print.jhtml (last visited Aug. 28, 2002). According to EEOC lawyers, BNSF became one
of the first companies to admit using genetic tests on its employees. See id. Advocates of
the new federal legislation are quick to point out that the BNSF case is not the only
example of an employer misusing an individual's genetic information, but rather that the
EEOCIBNSF case's high profile has "legitimized the cause." See MacDonald, Congress
Takes Up Genetic Privacy, supra note 20.
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to court litigation " Third, there is no statute of limitations in either
Title of the bill.ym Finally, and possibly most importantly, there is no
sunset clause in the proposed federal genetic nondiscrimination bill.20
For legislation that may precede actual court cases claiming genetic
discrimination, Congress should require a re-examination of this
210prophylactic legislation in a few years.
C. State and Local Attempts: Maryland's Genetic Nondiscrimination
Law and Montgomery County's Amended Human Relations Code as
Models for Federal Law
Perhaps a bigger problem than the technical aspects of the proposed
bill is the reality that the federal government has severely fallen behind
the states when it comes to protecting its citizens from genetic
discrimination.' In March of 2001, Maryland joined a long list of states
207. See S. 318 § 102(g)(2) (relating to the date on which collective bargaining
agreements under the Public Health Service Act become enforceable); H.R. 602 §
102(g)(2) (same).
20& See, e.g., S. 318 § 208 (civil action); H.R. 602 § 207 (civil action).
209. See, e.g., S. 318 § 211 (effective date); H.R. 602 § 211 (effective date); see also
infra note 210.
210. See 107th Congress, July House Hearing, supra note 148, at 75 (testimony of
Harold Coxson). Coxson testified:
Today's genetic nondiscrimination legislation may quickly become outdated, and
indeed counterproductive to its original purpose, unless it is drafted to avoid
"unintended consequences" to the extent possible. The very information that is
being censored today will very likely be the information that must be shared in a
year or two to help someone delay the onset of disease or avoid it entirely....
[O]ne way to avoid the risk of legislation which becomes out-dated "before the
ink is dry" is to mandate Congressional review or study of the legislation within a
few years of its enactment.
Id.
211. See Heath, Zipping Up Genes Discrimination, supra note 95, at 2346-47 (noting
that while Congress is still debating the pros and cons of federal nondiscrimination
legislation, twenty-eight states have already passed laws banning genetic discrimination by
employers). Overall, thirty-two states have laws providing some protection for health
insurance, employment, or, like the proposed federal legislation, both health insurance
and employment. See generally Goldberg, supra note 17, at 22-24. Some of the first state
statutes to address genetic discrimination focused on particular genetic conditions. See
Congressional Research Service, supra note 24, at 15. North Carolina was the first state to
prohibit employment discrimination based on an identifiable sickle cell trait. Id. In 1991,
Wisconsin was the first state to enact a comprehensive law, and it was signed by then-
Governor Tommy Thompson, now the Health and Human Services Secretary. See Heath,
Zipping Up Genes Discrimination, supra note 95, at 2347. President Bush signed a similar
law in Texas in 1997 while he was governor of the state. Id. Nonetheless, commentators
see the recent power shift in the U.S. Senate to be the impetus Congress needs to finally
tackle the issue. See id. Some scholars have contemplated possible state common law
actions in tort as a possible way to bring cases of genetic discrimination, but the state laws
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that have enacted their own laws to combat genetic discrimination.21 2
The Maryland law bars employers from requiring job applicants to
submit to genetic testing as a condition of employment.2 The law also
prohibits genetic information from being used as a factor in any
employment decisions such as raises, wages, and bonuses.214 Similar to
the proposed federal law, the Maryland law makes unlawful any
discrimination in employment simply because the individual has a genetic
predisposition for a disease or disability.25 Unlike the proposed federal
legislation, but similar to other federal nondiscrimination laws such as
the ADA, Maryland's new law only applies to employers with fifteen or
more employees.1 6
In August of 2001, Montgomery County, Maryland, home to both
NIH's Human Genome Project and the privately funded Celera
Genomics, amended its human relations code and became the first local
jurisdiction to adopt a genetic discrimination law.21'  The law now
includes employee protection against genetic bias and puts genetics on
par with other human rights protections afforded to race, religion,
national origin, age, disability, gender, and sexual orientation.1 8 Unlike
vary widely and may not cover every instance of discrimination if there is no duty required
by law. See Miller, supra note 13 at 257-60 (surveying extensively state legislation in this
area as it relates to genetics). For a comprehensive survey of state statutes addressing
genetic discrimination, see Congressional Research Service, supra note 24, at n.51, 52
(citing research by the National Conference of State Legislators). The National
Conference of State Legislators can be accessed at http://www.ncsl.org.
21Z See Michael Dresser, Genetic Privacy Measure Gains: Legislature Approves Ban
on Using Data in Hiring and Firing, BALT. SUN, Mar. 23, 2001, at 1D; see also Miller,
supra note 13, at 259-63 (surveying the states that have already enacted genetic
nondiscrimination legislation and describing some of the features common to most state
statutes).
213. See MD. ANN. CODE. § 16(a)(3) (Supp. 2001); see also Dresser, supra note 212
(noting that the "bill bars employers from requiring job applicants to submit to genetic
testing as a condition of employment").
214. See MD. ANN. CODE. § 16(a)(1), (2) (Supp. 2001); see also Dresser, supra note
212 (stating the Maryland law makes it illegal to use genetic information in making
decisions about wages and benefits).
215. See MD. ANN. CODE. § 16(a)(1), (2), (3) (Supp. 2001). At the time the Maryland
law was enacted to cover employment practices, the state already had a law protecting
people from genetic discrimination in health insurance practices. See Dresser, supra note
212.
216. See MD. ANN. CODE. § 15(b) (1998) (defining employer to be "a person engaged
in an industry or business who has fifteen or more employees for each working day...").
217. See Stephen Manning, Montgomery Human Rights Laws Expanded to Genetics,
ASSOCIATED PRESS, Aug. 13,2001.
218. See MONTGOMERY COUNTY, MD., CODE § 27-1(a) (2001) (stating the policy of
Montgomery County to eliminate discrimination, prejudice, intolerance, and bigotry on
the account of genetic status).
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Maryland's new law, the Montgomery County law only applies to county
employees.219 Also unlike Maryland's law, the Montgomery County law
applies to all employers and eliminates the seven-employee minimum
previously required in the original human rights law.2 0  Because
Montgomery County's regulations are more stringent than the state law,
it will take precedence over state law in situations where both county and
state law apply.
12
III. THE DISABILITY PARADOX: WHO WILL NEW LAWS HELP AND
WHO WILL THEY HURT?
As the name of the Genetic Nondiscrimination in Health Insurance
and Employment Act of 2001 correctly implies, the proposed federal
legislation would apply only to health insurance and employment genetic
discrimination claims, just as the local and state laws currently do.22
Beyond these contexts, where admittedly most cases of discrimination
are likely to occur, there are other ways genetics can be the basis for
discrimination, including adoption; prenatal diagnosis and reproduction
practices (childbearing decisions); admissions decisions; financial
assistance and credit approvals; and health, life, or disability insurance.2
Presently, neither the ADA nor the limited protections available through
219. See MONTGOMERY COUNTY, MD., CODE § 27-18 (2001) (defining employer).
220. See MONTGOMERY COUNTY, MD., CODE § 27-18(b) (2001) (deleting the original
bill's six employee minimum); see also Manning, supra note 217 (noting that the original
bill only covered employers with seven or more employees).
221. See Manning, supra note 217 (stating that Montgomery County's law will take
precedence over the Maryland state law).
222 See The Genetic Nondiscrimination in Health Insurance and Employment Act of
2001, S.318, 107th Cong. (2001), available at http://thomas.loc.gov (last visited Aug. 28,
2002); The Genetic Nondiscrimination in Health Insurance and Employment Act, H.R.
602, 107th Cong. (2001), available at http://thomas.loc.gov (last visited Aug. 28, 2002); see
also Heath, Zipping Up Genes Discrimination, supra note 95, at 22 and accompanying text
(noting the states that have coverage for employment discrimination); see also Goldberg,
supra note 17 and accompanying text (detailing state law coverage). In a Report to
Congress, it was noted:
It should be emphasized that legal issues relating to genetics may vary depending
on whether insurance, employment or other types of discrimination, or medical
research are involved. Approaches to addressing the issues raised in these
contexts vary from taking no legislative action, addressing certain specific
concerns (as was done in the Health Insurance Portability and Accountability
Act), or more far reaching approaches such as comprehensive legislation on
genetics or legislation focused on all medical records, including genetics.
See Congressional Research Service, supra note 24, at 4.
223. See Patrinos & Drell, supra note 4 (listing the issues ELSI identified to have
potential legal ramifications).
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HIPAA or the executive order will remedy this situation.224 Not even the
proposed federal law will fully remedy the situation, because as the list
above illustrates, the problem of genetic discrimination has the potential
to extend far beyond health insurance and employment. 22
Overall, the Genetic Nondiscrimination in Health Insurance and
Employment Act of 2001 is an attempt to legislate an area that has
already been partly legislated. However, the coverage is unpredictable
and the focus of the existing laws uncertain. 26 There are many gaps with
the current version of the proposed federal legislation, including the
reality that it may conflict with existing laws and that its provisions, as
drafted, are severely inconsistent with similar anti-discrimination laws
such that the proposed law loses credibility.227 Moreover, there are
technical flaws with the legislation that both provide loopholes and
create gaps in protection that, ultimately, defeat the purpose of enacting
federal genetic nondiscrimination legislation in the first place. 2 The
federal government has a duty to provide legal protection to the
citizenry. Before Congress enacts a piece of landmark legislation, it is
necessary to first understand all of the issues involved - ethical, social,
moral, and legal - and to balance these interests in a way that allows
meaningful laws to be created and privacy to be protected.
Any new law must comply with existing federal anti-discrimination and
civil rights laws, such as the ADA, the Civil Rights Act of 1964, the Age
Discrimination in Employment Act (ADEA), and others.229 In order to
accomplish that end, proposed legislation must not circumvent the
224. See Goldberg, supra note 17, at 22-25 (noting that HIPAA is limited in scope, the
Executive Order's limitation is that it only applies to federal employees, and that the
ADA's limited protection has not yet been tested by the courts and is thus uncertain).
225. See generally Patrinos & Drell, supra note 4; see also Kourtney L. Pickens,
Comment, Don't Judge Me By My Genes: A Survey of Federal Genetic Discrimination
Legislation, 34 TULSA L. J. 161, 180-81 (1998) (concluding that federal anti-discrimination
legislation must not be limited to employment and health insurance, but must extend to
life, automobile, disability and other forms of insurance; loan, mortgage, and credit card
agencies; reproduction practices; adoption practices; and schools).
226. See Goldberg, supra note 17, at 25-28.
227. See supra notes 146-93 and accompanying text.
228. See supra notes 194-210 and accompanying text.
229. See Daschle Genetic Discrimination Bill Would Hurt ADA, Civil Rights, supra
note 144 (reporting Senate Health, Education, Labor and Pensions Committee Member
Michael Enzi's belief that a bill to prohibit genetics-based discrimination "would damage
the Americans with Disabilities Act (ADA) and existing civil rights legislation"). Enzi
said that he and others in Congress "believe the bill would 'upset the balance of interests
created by existing employment nondiscrimination statutes' and would 'undermine the
process for enforcing and redressing civil rights legislation."' Id.
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accepted processes established for dealing with violations. 23 In addition,
a new federal law must not conflict with existing law and, in essence,
should not re-legislate an area already regulated.
To this end, the solution may entail amending existing civil rights laws
to include genetics. The Americans with Disabilities Act was a lauded
new law over a decade ago, but today, as a result of recent Supreme
Court decisions narrowing its scope and questioning its constitutionality,
there is no guarantee that it is a reliable sword to use in an action for
genetic discrimination.2" Amending the ADA would not be easy, but it
would be a good idea. 2 Amending the Civil Rights Act of 1964 to
include a ban against discrimination based on genetic predispositions is
also a possibility. This option could avoid cries of genetic exceptionalism
because it would put genetics on the same level as race, gender, national
origin, and religion - in essence creating a new "right." 3 Genetics is the
230. See id. (detailing critics' view that side-stepping the administrative procedures in
place in other federal civil rights laws is unjustifiable).
231. See Congressional Research Service, supra note 24, at 11-13 (outlining the Court's
recent decisions in Sutton and Bragdon and the potential difficulty plaintiffs may have
persuading a court to adopt the EEOC view that genetic discrimination is covered under
the ADA). The constitutionality of the ADA has come under attack recently as well, and
it could be argued that the proposed bill could be attacked on similar grounds, but that
discussion will not be tackled here. See Board of Trustees of the Univ. of Ala. v. Garrett,
531 U.S. 356 (2001) (finding that Congress did not adequately abrogate states' immunity
when enacting the ADA using its authority under section 5 of the Fourteenth
Amendment); see also Roger C. Hartley, Enforcing Federal Civil Rights Against Public
Entities After Garrett, 28 J.C. & U.L. 41-44 (2001) (discussing the recent federalism revival
in the Supreme Court and Congress' power to abrogate states' judicial immunity).
232. See 107th Congress, July House Hearings, supra note 148, at 75-76 (testimony of
Harold Coxson) (noting the difficulty in amending controversial federal labor and
employment laws such as the ADA). Furthermore, due to recent Supreme Court
decisions unfavorable to the rights of the disabled, it is likely that the disability community
would rather not test the ADA in a genetic discrimination case for fear that the Court
would further restrict the reach of the civil rights law.
233. See Miller, supra note 13, at 264. Miller notes:
Employment civil rights laws are rooted in the principle that certain
characteristics such as race, national origin, gender, religion, age, or disability
may not be considered in making employment decisions because they are
ultimately irrelevant to the person's ability to perform the job in question.
Discrimination based upon genetic information is no different.
Id. But cf Ross, supra note 156, at 141 (analyzing the labeling of HIV health policy as a
policy of exceptionalism, comparing genetic policy to HIV policy, and concluding that
what is needed is a paradigm shift such as the one that transformed HIV policy). Ross
argues:
[P]olicies and practices that promote genetic exceptionalism are not morally
justifiable because genetic information is not qualitatively different from other
medical information. As such, we should eliminate such practices now, before
they become routine, and avoid writing policies, laws, and regulations that will
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future, and it is important for the law to keep up with and stay consistent
with science.24
IV. CONCLUSION
It is clear that genetic discrimination presents a serious problem. Over
half the states have enacted new laws or amended existing ones to
provide protection for this new kind of discrimination. This area is one
where federal law can be a pioneer by covering all areas where genetic
discrimination may occur and by ushering in a standard of genetic
privacy. The Genetic Nondiscrimination in Health Insurance and
Employment Act of 2001 is a step in the right direction, but it should not
be the end. Changes are necessary, and more discussion is needed to
ensure that any law Congress enacts is both consistent with existing
federal discrimination and civil rights laws and that it does not create
more hardship than benefits. Until it can be proven that the proposed
law meets those goals, it should not be enacted.
V. ADDENDUM
Following the terrorist attacks on September 11, 2001, the Genetic
Nondiscrimination in Health Insurance and Employment Act was
pushed to the legislative back burner. 3' While President Bush has
endorsed a bill to protect against genetic discrimination, at the end of the
107th Congress, the Act was stalled in committee negotiations,
particularly in the House of Representatives, where professional staffers
stated that the bill was "unlikely to come to a floor vote in the House this
entrench these practices further. Instead, it may be instructive to consider how
the issues raised by genetics can be transformative for our conceptions of health
and disease.
[I]nstead of being treated as exceptional, genetics should serve to herald in a new
era of clinical medicine - an era in which the concepts of health, disease,
causality, and risk are incorporated into a new paradigm of health care that
focuses on prevention. Even if genetics does not successfully catalyze clinical
medicine, we must avoid the misunderstandings and misuses of genetics that
foster the false need for policies that treat it as exceptional.
Id. at 145.
234. See Miller, supra note 13, at 265 (stating that "[wihile advances in genetic
research and technology portend tremendous benefits for humankind in medicine and
science, adequate protections must be in place to insure that such technology will not be
used for the wrong reasons").
235. See After Tuesday, Health Issues Become Lower Priority On Hill, CONG. DAILY
AM, (Sept. 13, 2001), available at 2001 WL 27552230 (noting that some matters may be
put off until later while Congress focuses on the aftermath of the September 11th attacks).
2002]
Catholic University Law Review
session unless committee negotiations yield a consensus that the
Republican leadership can support. ' '
In the Senate, S. 318 has been competing with a second genetic
nondiscrimination bill, S. 382,z3 which was introduced by Senator
Olympia Snowe (R-Maine) and supported by many GOP senators and
independent moderates.3 Senator Snowe's bill has also found support
with the Bush administration, which does not want to "prohibit any
information on current health status from being available to health
plans." 239 The bill also seeks to address what GOP moderates see as
problems in S. 318, namely that that bill has broad definitions.25
Furthermore, S. 382 specifies that predictive genetic information is
limited to "tests that seek to assess disease risk in asymptomatic or
undiagnosed persons" and distinguishes between protected genetic
information and predictive genetic information.24' However, unlike S.
242318, S. 382 does not provide protection in the employment arena.
Despite the presence of a competing bill in the Senate, the original
sponsor, Senator Daschle, remains optimistic that the Genetic
Nondiscrimination in Health Insurance and Employment Act will see
Senate action soon.2'3 Even though the legislative session came to a close
in December 2002 with no significant action on either H. 602 or S. 318,
supporters of genetic discrimination legislation remain confident that the
bill will be considered in the next term of Congress.
244
236. See House Health Leaders Confident in Position on Genetic Discrimination Bills,
14 HEALTH NEWS DAILY 24 (2002) (noting House Republicans' concerns and declaring
that genetic nondiscrimination has only been a front-burner issue since President Bush
mentioned the topic in a July 2001 radio address).
237. Genetic Information Nondiscrimination in Health Insurance Act of 2001, S. 382,
107th Cong. (1st sess. 2001).
23& House Health Leaders Confident, supra note 236, at 24 (noting that some Senators
on the HELP Committee prefer the Snowe bill over Daschle's bill).
239. See Bush Preference for GOP Genetic Nondiscrimination Bill Hinted at by
Official, 45 BLUE SHEET 13 (2002) (noting that the Bush administration shares a policy
goal with the sponsors of the Snowe bill).
240. Id.
241. Id.
242. See id. (noting Senator James Jeffords' announcement during a committee
hearing that S. 382 sponsors are "working on adding employment protections to their
bill").
243. See House Health Leaders Confident in Position on Genetic Discrimination Bills,
supra note 236 (noting that Daschle "is passionate enough about the issue that he will
bring his legislation directly to the floor if necessary").
244. President Bush, a supporter of a genetic nondiscrimination bill in one form or
another, renewed his support in the winter of 2002 by stating that "genetic information
should be an opportunity to prevent and treat disease, not an excuse for discrimination;
just as our nation addressed discrimination based on race, we must now prevent
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Finally, though the disability community lost the "Father of the ADA"
when long-time advocate Justin Dart died on June 22, 2002, the initial
spirit of the ADA remains alive with many members of Congress, even
though some members unsuccessfully attempted to amend the ADA to
be more restrictive before the close of the legislative session. 4' The
ultimate fate of both the Genetic Nondiscrimination in Health Insurance
and Employment Act and the ADA remains to be seen.
discrimination based on genetic information." Bush Preference for GOP Genetic
Nondiscrimination Bill Hinted at by Official, supra note 239.
245. See Justin Dart, Jr. Dies; Activist Battled for Rights of Disabled, WASH. POST,
June 23, 2002, at C6; see also Debate Over Proposed Changes in ADA, 26 MONTANA
LAWYER 34, Jan. 2001 (noting that "in the past year, a handful of other measures have
been proposed to amend the act - and this fact has some disability advocates concerned").
But see ADA Notification Act, H.R. 914, 107th Cong. (2001), available at http://
thomas.loc.gov. The ADA Notification Act is an attempt by some members of Congress
to amend the ADA to require plaintiffs to give defendants thirty days notice of an alleged
violation of Title III of the ADA. Id. Proponents contend such an amendment is
necessary to put an end to frivolous litigation, while critics argue it is simply an attempt by
legislators to further restrict the reach of the ADA. See generally Kristin Loiacono, ADA
Notification Act: Delaying Justice for People with Disabilities, 36 TRIAL 10 (July 2000)
(noting Florida Representative Mark Foley's attempt to amend Title III of the ADA).
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